modifiable occlusive dressing kit and its construction method

专利摘要:
modifiable occlusive dressing kit and its method of construction this application relates to modifiable occlusive fabric dressings and methods including an elastomeric curtain and a liquid component, at least partially cross-linked at least after drying and / or curing, suitable for application to an interface dressing-skin in order to create a substantially hermetic seal. the same liquid component or a different one can be applied by a user in a tube-dressing interface in order to create a similar hermetic seal around the tube, if not occlusively sealed during manufacture
公开号:BR112014017625B1
申请号:R112014017625
申请日:2013-01-18
公开日:2019-12-24
发明作者:Danielle Zurovcik
申请人:Worldwide Innovative Healthcare Inc；
IPC主号:

专利说明:

Descriptive report of the invention application “MODIFICABLE OCCLUSIVE DRESSING KIT AND ITS CONSTRUCTION METHOD”
CROSS REFERENCE TO RELATED APPLICATIONS [001] This application claims priority for United States Patent Application No. 13 / 745,690 filed on January 18, 2013 and United States Provisional Application No. 61 / 588,121 filed on January 18, 2013 2012.
FIELD OF THE INVENTION [002] This invention relates to dressings designed to provide an impermeable barrier on the skin for fluids and, more particularly, to dressings suitable for the treatment of negative pressure wounds.
BACKGROUND OF THE INVENTION [003] Negative pressure wound treatment (NPWT) is an effective technology for treating open wounds. NPWT devices were originally accepted by the US Food and Drug Administration (FDA) in 1995 when the FDA approved a 510 (K) for Kinetic Concepts Inc.'s V.A.C.® device (“KCI”). The FDA's definition of devices for NPWT has changed over the years; in general terms, its definition is: a system that is used to apply negative pressure for the purpose of treating wounds, including fluid removal (for example, wound exudates, irrigation fluids and infectious materials). Negative pressure is applied through a porous dressing positioned in or on the wound cavity, depending on the type and depth of the wound, or on a flap or graft; the dressing distributes pressure when removing fluids from the wound. Systems for NPWT typically include:
• A non-adhesive dressing used to fill the wound cavity (for example, as a sponge or sterile medical gauze; also known as non-adhesive materials for tamponade); . . . • Drainage tube placed adjacent to or in the dressing;
• Transparent occlusive film placed over the dressing (and potentially over the drainage tube) and adhered to the skin to maintain a seal; • Collection container for the fluids drained from the wound; and • Low pressure vacuum source.
2/49 [004] The NPWT has been approved by the FDA for the treatment of many types of wounds: chronic, acute, traumatic, subacute and dehiscent wounds, partial thickness burns, ulcers (such as diabetic, venous or pressure), incisions surgically closed (also known as closed surgical incisions), flaps and grafts. The length of treatment prescribed depends on the type of wound, the dimensions of the wound and the patient's condition, usually lasting from four weeks to four months. The components of the disposable dressings are changed approximately every three days.
[005] Extensive clinical tests have demonstrated the success of negative pressure in healing approved types of wounds, by applying a controlled negative pressure typically between 20 mmHg and 200 mmHg. Most studies applied a constant vacuum pressure, 125 mmHg being the most common, although cyclical and intermittent studies are in progress. The evidence supporting the use of NPWT in the treatment of chronic, non-healing wounds exists mainly in the form of controlled, non-randomized tests, large and small series of prospective and retrospective cases, single-center studies and single case studies, with clinical tests controlled, little randomized. There are also studies that demonstrate the benefits of NPWT in healing acute wounds. In addition, since 2006, the benefits of treating surgical incisions in the postoperative period have been shown, with better clinical results, at least ten studies have been published to date. From these studies, the proven medical benefits of NPWT treatment include:
• Promotes blood flow (perfusion) in the wound;
• Removes interstitial fluid (also known as wound exudate), reduces edema;
• Reduces the count of bacteria and infectious materials;
• Increases the rate of granulation tissue formation, reduces the formation of scar tissue, increases growth factors and fibroblasts.
• Draws the edges of the wound together and uniformly;
• Provides a protected healing environment; and • Provides a humid environment.
[006] Although there is significant clinical evidence to support the benefits of NPWT as a safe treatment in healing chronic wounds, it is possible that during NPWT a vein or artery rupture occurs.
3/49
Generally, a machine safety alarm will represent a fluid leakage rate exceeding the rate for which the machine was designed. This rate of leakage from the alarm includes the combination of both air and liquid and typically has a safety limit higher than the minimum possible blood flow rate, outside a wound cavity, with an actively bleeding vein or artery. If a vein or artery ruptures accidentally, the system must be turned off. Therefore, it is very important to have a safety device that stops the blood flow in case this rupture occurs, so as not to allow blood loss by the patient.
[007] Lina et al. described in United States Patent No. 7,611,500 and WO1996 / 005873 an initial apparatus used for NPWT. In practice, the device proved to be effective, however, an important limitation was detected: the large source of electrical power, necessary to operate the device, limited the patient's mobility. For this reason, future refinements, such as that described by Hunt et al. in United States Patent No. 6,142,982, they incorporated rechargeable batteries into the power source. The batteries increased the patient's mobility, but time was limited by the battery life between charges. In addition, battery management became an issue, especially for facilities with a large number of patients with NPWT and the power grid still remained necessary to recharge the batteries.
[008] Eliminating the need for electricity, through the network or batteries, would create a clinically viable treatment, with wider application. The variability of the energy requirement of a system is dependent on the desired vacuum pressure, the rate of removal of exudate from the wound cavity and the rate of air leakage within the system. As the rate of air leakage increases, more energy is needed to supply a continuous negative pressure at a predetermined value or limit range in the wound bed. Air leakage in the NPWT system requires more energy than any other component. Air leaks are obstacles to creating a vacuum system that does not require a continuous external power source or frequent recharging of its internal energy storage. Therefore, the viability of a mechanical system for NPWT is strongly dependent on the quality of the seal of each interface of the system. The dressing system was identified as the main source of air leakage in the current systems for NPWT, especially at the interfaces between 1) the dressing and the skin and 2) the tube and the
4/49 dressing. The amount of air leakage at these interfaces determines the frequency of times the pump needs to be refilled and the magnitude of the vacuum pressure applied to the wound cavity at a specific time. These last two characteristics are dependent on the system parameters.
[009] Currently, there are few mechanical systems for NPWT, as described by the present inventor in Development of a Simplified Negative Pressure Wound Device presented in 2007 for his Master of Science in Mechanical Engineering at the Massachusetts Institute of Technology. Later, some low-pressure mechanical devices were disclosed by Hu et al. in United States Patent Application No. 2010/0228205. Current mechanical systems generally use flat dressings of sophisticated material, such as hydrocolloid dressings, to try to solve the problem of air leakage. However, the inherent geometric incompatibility of a planar dressing in relation to the contoured surface of the skin often induces air leaks. Therefore, mechanical devices are only applicable to relatively flat body surfaces and it is still difficult to completely eliminate air leaks.
[010] Non-electric pumps are at the bottom end of the medical pump spectrum, typically using balloon pumps and capillary action materials. Balloon pumps are used to both extract and insert fluids. Due to their physical characteristics, they are governed by non-linear, spring-like properties. Currently, balloon pumps are used in wound treatments for drainage purposes, especially for internal drainage of the body cavity. C. R. Bard, Inc. produces many of these non-electric pumps; a balloon model often used to drain internal cavities is generally referred to as a Jackson Pratt Drain.
[011] There are several limitations to the application of NPWT with current mechanical balloon pumps. There are no gauges on the pumps and therefore the user is unaware of the initial magnitude of the negative pressure pulled and cannot monitor the pressure during treatment. In addition, current pumps do not have air leak detection systems, except the possibility of visually observing the expansion of the balloon at a higher rate than expected. If the pump is clear, it is also possible to visually monitor whether the expansion rate is due to air leaks or drain fluid.
5/49 [012] Capillary action materials are also currently used to treat wounds, providing treatment with very low negative pressure, too low to be considered an NPWT. Typically, this form of treatment is found in dressings, such as small topical bandages, to provide NPWT-type benefits for very small, self-healing wounds such as blisters and friction burns. Treating a wound with this technology improves the healing environment. Capillary action materials are filled with small capillaries between the wound and the external environment. A negative pressure is applied by the capillary action of the fluid that flows from the wound to the external environment, thus removing the interstitial fluid. Johnson & Johnson Advanced Care First Aid Adhesive Dressings for Advanced Treatment is an example of a capillary action material.
[013] Dressing technologies have attempted to address the issue of air leaks in NPWT systems. This is important for both the electrical system and the mechanic to reduce their energy needs. In mechanical systems it is necessary for the functionality of clinically important devices, so that the time of energy input and pump recharge is reasonable for the performance of a caregiver and / or patient. For electrical systems, reducing air leakage reduces, or even completely eliminates, the number of emergency system shutdowns alarmed by false positives. The reduction of air leakage allows the design of batteries that last longer on a single charge and with lower energy capacities. Eliminating air leakage eliminates the need for continuous energy supply, as vacuum pressure can be maintained in the occlusive environment within a specified limit, for which the time period depends on the pump parameters and the rate of removal of exudate from the wound (typically less than 100 mL / day).
[014] Currently, most NPWT dressings (the curtain component) are thin, flat, adhesive tape-type dressings that should be applied to the contoured skin area. The protective coating on the dressing must be removed to expose the adhesive and then the dressing is applied to the skin. The handling of the pre-application of the adhesives alone introduces a probability of air leakage, since the dressing generally bends on itself or very easily forms creases due to its low flexural rigidity; many dressings are thinner than a standard piece of paper and the flexural rigidity of a material is proportional to the
6/49 inverse of its cubed thickness. When a dressing is applied, it must often fold over itself to accommodate a geometric mismatch between the planar dressing and the body contour around the wound to be treated. This crease crease in the dressing, in this document also referred to as wrinkle, has a high potential to cause air leakage in an NPWT system.
[015] In addition to geometric incompatibility, dressings often become less adhesive due to the introduction of foreign materials on the adhesive before applying the dressing. This fact is very common and almost inevitable on the margins of the dressing due to manipulation by the caregiver. Sometimes, the caregiver's hands introduce foreign particles to the adhesive in sufficient quantity to prevent further adherence of such dressing area. In the United States, this usually occurs when a caregiver uses powdered gloves. This is a critical point, since the dressing margins constitute an area where the leakage spread from the dressing edge to the wound cavity is potentially very high, based on the theory of interface fracture mechanics.
[016] For electrical NPWT systems, a thin plastic dressing is usually used, with adhesive on the back. The electrical systems for NPWT dressings did not readily address the issues of air leaks that form at the dressing-skin interface. On the contrary, interactions were concentrated on air leaks at the tube-dressing interface. When NPWT was first introduced to the market, the drainage tube was inserted into the wound cavity through the edge of the dressing. This fact introduced a high potential for air leakage, which often alarmed the shutdown system. Caregivers began to solve this problem by increasing the tube from the skin surface at the edge of the dressing and securing the dressing under the tube before the dressing came into contact with the skin. This caused the dressing to stick to itself in an upside-down "T" pattern.
[017] Eventually, some commercial NPWT dressing designs incorporated their own solutions for the high rate of air leakage at the tube interface. Since these solutions, the T.R.A.C. from KCI was highly effective, which is driving trends in the current project. The T.R.A.C. Pillow prefabricates the drain tube in relation to a semi-rigid tube connector, which is then attached to a small, circular, flat adhesive bandage (also known as
7/49 curtain). All of these connections are manufactured to be airtight. The tube does not go beyond the plane of the adhesive dressing and, therefore, its opening remains on the skin surface. When the T.R.A.C Pad is used, the standard dressing is initially applied to the wound, without a tube connection. Next, a small incision is made in the dressing over the wound cavity. This hole can also be prefabricated in the curtain component of the dressing during manufacture. The back film of the circular adhesive component is removed from the pad and the tube opening is centered over the incision. Since the adhesive surface of the pad is small, handling is easier than the procedure of digging the tube into the initial dressing. Although the cushion does not guarantee the elimination of air leaks at the tube-dressing interface, it greatly reduces the probable amount of air leaks in the dressing, based on its ergonomic design and small profile. A minimal amount of air leakage is almost inevitable for all applications with flat adhesive components, due to the geometric incompatibility and user handling that still remain.
[018] Many efforts have been made to overcome the barriers identified in low-cost mechanical pumps for application in NPWT. The focus is usually on reducing air leakage and creating more predictable vacuum sources. The new materials used in NPWT dressings have been the main drivers for reducing the rate of air leakage in the system at the skin-healing interface. These materials are generally not new to dressings, however, they are new to NPWT. The pump design has been the focus for creating more predictable vacuum sources; Mechanical components, such as linear or constant force springs, are generally introduced into the system and maintain a more predictable behavior throughout the treatment.
[019] Only one mechanical system for NPWT is currently on the market, but it is not widely used: Spiracur's SNaP® Wound Care System (Sunnyvale, CA). The SNaP® System for Wound Care uses a hydrocolloid dressing with specific mechanical connectors from the tube to the dressing in order to adjust to prevent air leakage; the hydrocolloid dressing provided is relatively small in size. Hydrocolloids are used in many wound dressing systems and are trends in the NPWT market. They are stiffer and thicker than the most common adhesive and flat dressings specific to NPWT. This causes the dressing to fold less
8/49 on itself during handling and application. However, it cannot adjust to the geometric incompatibility without creating creases, especially as the surface area of the dressing increases. Since the dressing is more rigid and thick, it is difficult to seal the creases in an airtight manner, due to the increased resistance to flexion. Therefore, hydrocolloids are generally applicable only to minor wounds. Currently, a lot of effort has been made to make them thinner in order to increase their applicable surface area and adjust more to contours, such as the Replicare Thin Hydrocolloid Dressing from Smith and Nephew. Hydrocolloids have their extremely sticky adhesive properties to explain their greater adhesion to the skin and lesser air leaks. If they come into contact with the wound exudate, the polymers in the hydrocolloid will swell with water until saturation, forming a gel, which is kept in a solid state in its adhesive matrix structure.
[020] In the SNaP® System for Wound Care, hydrocolloid dressings are attached to the tube using a mechanical connector component, similar to the T.R.A.C. from KCI. The SNaP® System for Wound Care eliminates any potential air leaks from this mechanical connector by prefabricating it in relation to the center of the dressing as a whole during the manufacturing process. Pre-fabrication eliminates any potential air leaks at the tube-dressing interface due to the user interface and geometric incompatibility, but it is not able to move over the dressing surface. Therefore, it may need to be placed over an inconvenient area of the wound, such as a location that is uncomfortable for the patient. In addition, the tube extends parallel to the curtain plane; the direction of the tube along the curtain plane is fixed. Considering that the dressings are generally not round, it may be necessary for the tube's path to follow an undesirable path, in order to cover the wound area with the predefined curtain shape.
[021] For your vacuum source, the SNaP® Wound Care System uses a complex system, driven by constant force springs. Thus, as the pump expands, mainly because of air leaks and exudate removal, the pressure remains relatively constant during the extension of the pressure application. This system is expensive and highly technical compared to non-electric pumps at the bottom end of the medical pump spectrum (for example, balloon pumps), however, it is the first pump
9/49 commercial mechanics for NPWT which has proven to be a potential pump concept for NPWT. Since air leaks in the dressing system remain highly likely, depending on the location of the wound and the caregiver's experience, the successful application of the SNaP® System for Wound Care in practice is limited.
SUMMARY [022] Occlusive dressings according to the present invention preferably provide one or more of the following advantages:
• an adjustable dressing system that can be changed, if desired, and applied to most areas of the skin surface;
• a dressing system that is ergonomic;
• dressings that are easy to obtain and retrieve by the user, due to convenient storage;
• dressings, pumps, systems and methods for administering NPWT without the need for electricity;
• minimize the amount of air leakage within the system for NPWT; • detect air leaks within the system for NPWT;
• pumps compatible with light weights, easily transportable and low cost; and • mechanical methods to minimize the possibility of blood loss by the patient.
[023] The occlusive dressings according to the present invention overcome the aforementioned drawbacks as they are truly hermetic. A primary application of this technology is to facilitate the administration of mechanical NPWT. A liquid component is applied to the dressing-skin interface in order to create a significantly hermetic seal, preferably for at least 48 hours, more preferably for at least 72 hours. Preferably, the same liquid or a different liquid is applied to the tube-dressing interface in order to create an equally airtight seal. In some embodiments, the liquid components can be made of rubber polymers applied by touch, by compressing a container or by spraying polymers through an atomization process.
[024] This invention adds a suitable kit to occlusively seal a wound that penetrates a patient's skin, including a curtain formed as
10/49 a thin sheet, preferably of an elastomeric organic material, significantly impermeable to the fluid transfer of air and body fluids, presenting a first and a second surface. A biocompatible adhesive is at least one of (1) disposed on at least the first surface of the curtain and (2) capable of at least making contact with at least part of the first surface of the curtain. When the kit includes the biocompatible adhesive disposed on at least a part of the first surface of the curtain, the kit will also include at least one first removable covering sheet covering the first surface of the curtain. In some embodiments, a second removable covering sheet covers the second surface of the curtain, especially when the adhesive is also disposed on the second surface of the curtain. The kit also includes at least one container of at least one sealing component, which is capable of being delivered as a liquid sealant under pre-selected environmental conditions, the seal being at least partially cross-linked, at least after drying and / or curing , and which is capable of at least drying and / or curing in thirty minutes, preferably in twenty minutes and, more preferably, in ten minutes, after applying the sealant as a layer on the curtain edges after the curtain is applied over the curtain. skin around the wound.
[025] In some embodiments, the curtain and seal after drying and / or curing are elastomeric. In various embodiments, the curtain and seal are derived from the same material, such as a type of latex compound or a type of silicone compound. In certain embodiments, the adhesive is a silicone based adhesive and is arranged on at least most of each of the first and second curtain surfaces as a solid coating or in a pattern, such as a grid or concentric circles. At least one container of a sealing component allows manual application of the sealant in some embodiments, such as by compressing the container, and in other embodiments, at least one container is a removable bottle or insertable cartridge within a dispensing apparatus or other applicator. In several embodiments, the kit also includes a flexible tube that has a first end and a second end connectable to a source of negative pressure, such as a bellows, especially a new bellows that unwinds, or another mechanical vacuum source. Preferably, the kit also includes a flange that has at least one of (1) a central passage through which the first end of the tube is insertable and (2)
11/49 a central passage that communicates with a connector capable of coupling to the first end of the tube. In an embodiment, the first end of the tube includes a feature, such as a spiral cut, to prevent obstruction of the tube. In some embodiments, the kit includes at least one non-stick handling component. In several incorporations, the kit still includes at least one material for wound dressing.
[026] This invention can also be expressed as a method for building an occlusive dressing on a wound that penetrates a patient's skin, by selecting a curtain formed as a thin sheet of an elastomeric material, significantly impervious to fluid transfer. , and that has a first and a second surface. A biocompatible adhesive is selected so that it is at least one of (1) disposed at least on the first curtain surface, preferably with a first removable covering sheet covering the first curtain surface and (2) at least applied to a (i) the patient's skin around the wound and (ii) at least a part of the first surface of the curtain. Optionally, a second removable covering sheet covers the second surface of the curtain. The method includes removing the first removable liner, if any, and placing the curtain over the skin around the wound, removing the second removable liner, if any, and applying a sealant that is in liquid when applied, the seal being at least partially cross-linked at least after drying and / or curing, on at least the edges of the curtain and on the skin adjacent to the curtain in one or more layers. The method further includes at least drying and / or curing the sealant in thirty minutes, preferably in twenty minutes, after applying the sealant to the curtain edges in at least one layer.
[027] In certain embodiments, the adhesive is laid over at least most of each of the first and second curtain surfaces, and / or the method includes pressing on the second curtain surface in the vicinity of all wrinkles in the curtain , preferably before the sealant is applied in that vicinity. In some embodiments, the flexible tube is selected with a first end and a second end connectable to a negative pressure source, such as a bellows or other mechanical vacuum source. Preferably, the first end of the tube (1) is inserted through a central passage of a flange attached to the curtain or (2) is coupled to a connector on a
12/49 flange that has a central passage that communicates with the connector. In an embodiment, the first end of the tube includes a feature, such as a spiral cut, to prevent obstruction of the tube. In some embodiments, the wound is covered with gauze or other fluid-permeable material before placing the curtain on the skin.
[028] This invention can still be expressed as a method of building an occlusive dressing on a wound that penetrates a patient's skin, through at least one of (1) plugging the wound with a fluid-permeable material and (2 ) cover at least part of the wound with protective material. The method further includes applying, such as by spraying, an elastomeric material that is in a liquid state and is at least partially cross-linked, at least after drying and / or curing, on the buffered material and on the skin around the wound to create a occlusive curtain, like a thin sheet, significantly impermeable to fluid transfer, having a first inner surface and a second outer surface. The method includes at least drying and / or curing the elastomeric material within thirty minutes after applying the elastomeric material as a layer.
BRIEF DESCRIPTION OF THE DRAWINGS [029] Below, the preferred embodiments of the invention are explained in more detail with reference to the drawings, in which:
[030] FIGURE 1 is a schematic view in expanded perspective of a curtain, a flange and a tube with a first and a second coating, before applying a liquid seal according to the present invention.
[031] FIGURES 2 and 3 illustrate a new first end of the tube of FIGURE 1 being inserted through the new flange, preferably symmetrical;
[032] FIGURE 4 is a schematic perspective view of a new and alternative first end of a tube;
[033] FIGURES 5A and 5B illustrate the repositioning of the pipe vertically to a desired lateral orientation.
[034] FIGURES 6 and 7 show a curtain being covered by a topcoat to produce a dressing in accordance with the present invention; [035] FIGURE 8 shows a hole drilled in the dressing of FIGURE 7;
[036] FIGURES 9 and 10 show a set of tubes being inserted into the dressing of FIGURE 8 with the flange edge being sealed to the curtain;
13/49 [037] FIGURE 11 shows a protective coating being added to the dressing in FIGURE 10;
[038] FIGURE 12 illustrates how a user can cut the dressing in FIGURE 11 to fit a wound;
[039] FIGURE 13 shows a handling tab being added to the dressing in FIGURE 12;
[040] FIGURES 14 and 15 illustrate the debridement and tamponade of an open wound;
[041] FIGURE 16 is a perspective view of the bottom face of the FIGURE 11 dressing with the inner lower protective layer being removed;
[042] FIGURE 17 is a schematic top plan view of a dressing according to the present invention attached to the skin around the wound;
[043] FIGURE 18 is a schematic perspective view of the dressing in FIGURE 17 with the upper protective liner being removed;
[044] FIGURE 19 shows the liquid seal being applied to the curtain edges of FIGURE 18;
[045] FIGURES 19A and 19B illustrate the modification of the dressing coverage in accordance with the present invention;
[046] FIGURE 20 is an expanded schematic view of a bottle of sealant with a nonstick finger protector, optionally positioned inside the bottle for storage and transportation;
[047] FIGURES 21A and 21B show a dispensing apparatus with removable liquid seal cartridges;
[048] FIGURE 22 is an enlarged perspective view of the cartridge of FIGURES 21A and 21B;
[049] FIGURE 23A is a schematic perspective view of a manual compression applicator for liquid seals;
[050] FIGURES 23B and 23C are enlarged views of the outlet orifice with and without a removable tape covering the distribution openings;
[051] FIGURES 24 and 25 are schematic top plan views that illustrate non-stick gloves and finger protectors, respectively, integrated into the coating;
[052] FIGURES 26-28 are schematic top plan views of coatings with different shapes;
14/49 [053] FIGURE 29 is a schematic side view of a dressing in accordance with the present invention being applied to a heel of a foot;
[054] FIGURES 30 and 30A are enlarged schematic views of the dressing in FIGURE 29 with a fold being created and then flattened to improve the fit to the heel;
[055] FIGURE 31 is a cross-sectional view of a known bellows pump;
[056] FIGURE 32 is a perspective view of a new folding bellows pump;
[057] FIGURE 33 is a flow chart of the method of a sample of the occlusive dressing;
[058] FIGURES 34A and B are diagrams that compare NPWT systems with active versus passive flow;
[059] FIGURE 35 is a diagram of a method to prevent the dressing from weakening due to the accumulation of exudate in the passive NPWT system.
[060] FIGURE 36 is a diagram of some specific components of an occlusive dressing incorporation.
[061] FIGURE 37 is a diagram of a pipe connection method with a spiral-ended pipe.
[062] FIGURE 38 is a schematic top plan view of the wound shown in FIGURE 14 with the additional step of applying a protective covering over the wound;
[063] FIGURE 39 is a view of FIGURE 38 with a hole cut in the protective cover;
[064] FIGURE 40 is a view of FIGURE 39 with a set of tubes placed over the hole;
[065] FIGURE 41 is a view of FIGURE 40 with the material of the liquid curtain applied over the protective covering and the surrounding skin to build a dressing in accordance with the present invention;
[066] FIGURE 42 is a schematic perspective view of the dressing in FIGURE 41; and [067] FIGURE 43 is a schematic perspective view of a new flange according to the present invention with an integral connector.
15/49
DETAILED DESCRIPTION [068] This invention can be realized through a kit, system or dressing method, using a curtain formed as a thin sheet of an organic material, preferably elastomeric, significantly impermeable to the fluid transfer of air or body fluids, from preferably for at least 48 hours, more preferably at least 72 hours, having a first and a second surface. Preferably, a biocompatible adhesive is disposed on, applied to or placed in contact with at least the first surface of the curtain. In some constructions, a first removable covering sheet covers the first surface of the curtain and, optionally, a second removable covering sheet covers the second surface of the curtain. The invention further uses a container of at least one sealing component, which is capable of being delivered as a liquid sealant under pre-selected environmental conditions, the seal being at least partially cross-linked, at least after drying and / or curing, and that is capable of at least drying and / or curing in thirty minutes, preferably in twenty minutes and, more preferably, in ten minutes, after applying the sealant as a layer on the curtain edges after the curtain is applied to the skin when around the wound.
[069] The currently disclosed occlusive dressings address the issues of energy / mobility and air leakage to eliminate the need for an electrical power source and to reliably maintain airtight interfaces, particularly 1) in the dressing and skin and 2) in the tube and the dressing. The disclosed dressing systems and their connection methods allow reliable mechanical systems for NPWT. Not only does it eliminate the issues of patient mobility and battery management, but it also allows NPWT to be administered in austere environments, where electricity is often scarce and harsh environments that require robust products. Several disclosed incorporations support a robust, low-cost treatment method for global application. In addition, the dressings according to the present invention are compatible with MRI.
[070] In order to obtain an airtight dressing, the present occlusive dressings use a liquid sealant. This liquid sealant can dry and cure quickly, even immediately, or immediately effectively, after application to the skin or other dressing components, in a continuous occlusive film or sheet of material. The drying and curing processes can
16/49 occur simultaneously, they can be activated by evaporation, they may need a curing agent and / or accelerator, and / or they can be improved or controlled with a curing agent and / or accelerator. Any extra additives (eg curing agents and accelerators) can be added immediately before, during, and / or after the sealant application process, depending on its chemical reaction with the sealant and its reaction speed.
[071] The liquid seal attaches to the component (s) to which it is intended to seal. The ability of Van der Waals forces to provide the bonding strength without the addition of an adhesive is based on the material and its thickness. Theoretically, the peel strength (bond strength) should be greater than the peel energy and the peel energy is proportional to: material thickness, squared material stress and the material's elasticity modulus. Specifically (on a first-order basis; since its base is a small effort analysis), the bonding strength of a thin film must comply with Equation 1, where Γ is the peel strength, ς is the peel energy , Ω is a dimensionless pre-factor, h is the thickness of the film, ετ is the stress in tension and Ef is the elasticity modulus of the film, in order to maintain adhesion to the skin in tension:
r> ç = Qh _{£ T} ² E _f (1)
Therefore, a thin, highly elastic film has the ideal material properties for the necessary reduction of the adhesion force, increasing the functional applicability of the Van der Waals forces.
[072] To obtain a desired bonding strength, an additional adhesive, such as silicone-based, latex-based or acrylic-based glue, may be used, having one or more components (for example, Liquid Adhesive or Silicone tape, waterproof, by Walker Tape Co., West Jordan, UT). This adhesive can be applied under the liquid sealant or chemically mixed with the liquid sealant before application, depending on its chemical composition and properties of the final mixture. When applied under the sealant, the adhesive may need to become sticky (also known as a set time application) before the sealant overlaps. A two-part, quick-fit sealant that is mixed before use can be useful in some circumstances, such as the Skin Tite® silicone available from Smooth On, Easton,
17/49
Pennsylvania, which has an ACMI Safety Certificate and can be used alone or mixed with a thickener, such as Thi-vex® thickener, also available from Smooth On. A polymer sealant or other bonding material may be desirable. to a continuous occlusive sheet, with adhesive properties due to the high forces of Van der Waals, where no other adhesive is needed.
[073] Rubber polymers, such as latex, synthetic rubber and hypoallergenic latex, are examples of polymers with desired properties for both the skin-dressing interface and the tube-dressing interface. For example, both Latex Liquid Deviant, from Deviant, a subsidiary of Envision Design, San Jose, CA, and Latex Liquid Fashions for Body Painting by Liquid Latex Fashions, Warrington, PA, have been shown to seal the dressing on both interfaces. The drying and curing time for the latex has been significantly reduced by applying the liquid to the skin with an atomization process, which is disclosed in the sections below, by the addition of alcohol which helps to absorb the water that evaporates from the latex and / or by the flow of a gas through the seal for drying by convection. For most applications, the curing / drying time has been reduced to immediately (maximum 1 minute) from the 5-10 minutes previously set by Deviant at http://www.liquidlatex.net/.
[074] Examples of suitable latex materials include Vytex Natural Rubber Latex (NRL), a brand of natural rubber latex produced and marketed by Vystar Corporation, Duluth, GA. Vytex is produced by Revertex Malaysia and distributed by Centrotrade Minerals and Metals, Inc. Protein assay results show that Vytex NRL typically has 90% less antigenic proteins than Hevea natural rubber latex. Therefore, Vytex causes less exposure and development of latex sensitivities. Vytex has two products with different levels of ammonia; ammonia is a stabilizing and preservative agent, functionally, both are viable for the liquid sealant for NPWT and for curtain components, although stabilizers alternative to ammonia may irritate the skin less. Liquid latex for body painting usually contains ammonia, which is what was applied to patients during field studies without irritation. The product Vytex NRL, composed with little ammonia, has provided a curtain
18/49 occlusive and functional sealing components, in clean skin, without wound, in a laboratory environment.
[075] Yulex Corporation, Phoenix, AZ, produces hypoallergenic latex from guayule (Parthenium argentatum). Yulex guayoule bio-rubber emulsions and solids do not contain any of the antigen-sensitizing proteins found in traditional Hevea latex and are considered a safe alternative for people with Type I allergies. Yulex bio-emulsion emulsions are registered with the Yulex Products Council Personal Hygiene, its INCI name is Parthenium argentatum Bark Extract. This is the material currently preferred for the dressing and the NPWT sealant, in order to provide a choice of non-allergenic material. Currently, Yulex has ammonia and ammonia free options.
[076] Synthetic materials, such as nitrile rubber and neoprene, are options for natural rubber that do not contain allergy-causing proteins, but can generally have low elasticity with a greater risk of rupture rates and viral penetration rates. Therefore, they are less ideal for many applications of the dressing according to the present invention, but may be suitable in some circumstances, especially for the curtain in which curing on the skin and drying time are not a problem. Other materials with multiple parts, such as Room Temperature Vulcanization silicones and certain polyurethanes, which are two-part materials with a base and curative components, may be accepted in some applications.
[077] An extremely low stiffness, which is achievable with many rubber-like materials, increases its bonding capacity only through the forces of Van der Waals. The high elasticity, capable of being achieved through the use of rubber polymers, adjusts to the high levels of tension pressure reached on the skin surface during large movements of body deformation. In addition, the material properties of rubber polymers can also adjust to the tendency to sag when compression stresses are applied, depending on all initial sizes in the interface crack and the adhesion force. A desirable sealant adjusts to great variability over time and to the surface area of the skin surface stresses experienced during large human deformation movements; in the literature, the maximum strain strain indicated is approximately 0.45 in tension and 0.3 in compression. Since the mechanical properties of rubber are
19/49 sufficient to achieve structural integrity, the adhesive properties of Van der Waals determine the applicable occlusive sealants and, depending on the polymer, an additional adhesive may be required.
[078] The liquid sealant must have viscosity and curing properties, preferably including minimum shrinkage, which enables it to adjust to all contact surfaces during the application and curing processes, so that after its application it is not present no air leakage channels at the interface. At the dressing-skin interface, the sealant must adjust to the folds and creases in the skin, which are usually interconnected when a standard, flat dressing is applied. These types of cracks interconnected at all component interfaces are often important sources of air leakage in the system without a liquid seal. Once a crack exists, the crack propagation occurs in tension and compression with reduced applied stresses, so, over time, there may be the formation of air leakage channels with reduced stress magnitudes. Therefore, it is desirable to eliminate any initial cracks in all interfaces. At the dressing-skin interface, structures, such as hair, generally create opportunities for crack propagation and air leakage within the dressing, so hairs are generally shaved before dressing applications. The need to shave hair from an infectious point of view is not desirable, since the shaving process creates trauma to the hair follicles and increases the risk of infection. With a liquid seal, these structures can be completely enclosed in the hermetic seal and therefore are not a source for the crack to propagate under the seal and generally do not need to be removed before applying the seal, since the cracks in the dressing edges are more critical to the seal in order to resist crack propagation due to stress. In some constructions, the adhesive on the first surface of the curtain is sufficiently thick and / or flowable to seal around the hairs and fissures of the skin and to minimize the spread of the crack.
[079] The thickness of the seal, the number of components, the location of the wound and the viscosity of the seal determine the ideal method (s) of application. The liquid sealant can have viscosity from very high to low, as long as it can completely moisten the contact surfaces. If applied mechanically (for example, brush or “paint” application, roller application, sponge / touch application, squeegee or other pressure application, manual application (ie
20/49 with the finger) with or without a nonstick protector, etc.), a viscosity that prevents flow due to gravity is preferable, so that the seal is ergonomically applicable in any location of the wound. This leads to higher viscosities and is limited in the low viscosity range. Painting is not the preferred method of application; when painting the seal it is difficult to achieve a constant thickness. If the thickness over its surface area varies significantly, the mechanical properties and the detachment energy will vary significantly, which can cause the occlusive dressing to fail. Painting also offers other disadvantages, since air bubbles are easily trapped in the sealant, which are a source of cracks for the crack to spread. Furthermore, it is difficult to produce and maintain a very thin layer, which significantly increases the necessary Van der Waals bond strength; increases the stiffness of the final dressing and reduces its ability to adjust to the great stresses of the fabric.
[080] Spraying is a preferred method for applying the sealant. Two types of spraying procedures are possible: 1) an aerosol process that propels the liquid sealant with a pressurized liquid or propellant gas that forces the liquid sealant through an atomizing nozzle and 2) a shear process that cuts the sealant liquid with a pressurized gas or liquid causing atomization. When atomized, the layer of sealing material can be produced thin enough that flow is not a problem and therefore a lower viscosity range can be used for its desired wetting characteristics. In addition, and together, the small atomized particles fill the structures in the skin for moistening purposes. The spraying technique is limited in the high viscosity range, since a sealer with a very high viscosity cannot be sprayed with reasonable pressure and speed for application in the clinical environment on the skin. However, this is not seen as a negative aspect, since liquids with high viscosities generally do not wet the complex contours of the skin surface properly.
[081] The shear process can be preferred to the aerosol process. One reason for this preference is that the nozzles easily clog with long polymer chains, unless the liquid can be diluted. Using the shear process, the shear fluid and the sealing fluid can be kept separate until both become visible in the nozzle head.
/ 49
Thus, internal nozzle clogging does not occur when properly designed, including a fluid filter (if necessary) and an adequate nozzle orifice size. The preferred shear fluid is gas, as it does not add any liquid to the system, for drying reasons, it is easy to propel as it can be compressed to high pressure levels and helps to dry the seal when sprayed on the skin . Higher viscosities and materials with long polymer chains are capable of being sprayed by the shear method instead of the propellant method, although viscosities and chemical chains, which can be adapted with the propellant method, can be increased with a complex nozzle design.
[082] Additives, such as curing agents, accelerators, convection drying agents and adhesives, can be applied by means of separate application methods, if they are not mixed with the sealant before application. Its application methods can be through painting or spraying. The application of these additive components and the sealant can take place in a multi-stage process. They can be stored and applied from separate containers with the same or different application methods, in series or in parallel. However, they can also be applied in parallel or in series from the same container. An example is a parallel spraying process for which there are three ports: the seal port, the shear fluid port and an accelerator port; these three components can be combined during the atomization process in the spray nozzle where the three ports can interact. Another example is a spray device that allows the amount of sealant (and potential accelerator) to be controlled, in such a way that it can be turned off; the shear gas then becomes a convective drying gas.
[083] Various polymers with rubber-like properties have been determined for the desired seal properties. In addition, a preferred sealant cures immediately or within seconds after contact with the surface. With these characteristics, the polymer tends to have long and heavy polymer chains and, therefore, requires higher atomization forces, possible with the shear process. A gas is used to atomize the polymer, there is no desirable range for the combination of gas pressure, speed and volume flow, necessary for the desired film result
22/49 continues. Filtered air, pure oxygen and carbon dioxide are examples of applicable shear gases that can be used readily and are generally available in the clinical environment at the desired volumetric pressures and flow rates. They are also readily available outside the clinical setting. Using these gases, the necessary shear atomization process can be designed on a miniaturized handheld device. This process and the design are similar to the use by the consumer of the aerosol incorporation, normally found in consumer products and later disclosed in the section Methods of Application of the Dressing.
[084] The thickness of a desired seal incorporation can be improved in a rolling process in successive layers. It is desirable for a material that has a strong affinity for itself, either with strong Van der Waals forces or with chemical bonds that form between its layers, so that the final material behaves like a single-layer continuous seal. The desired thickness is the minimum thickness required for strength and to achieve the required occlusive properties, which depend on the material. This thickness is generally thinner than the thickness that can be achieved reliably and uniformly through a painting process and, therefore, a spraying process is generally preferable. The atomization process provides a method to achieve the thinnest functional seal thickness.
[085] Occlusive dressings are beneficial in addition to NPWT and in conjunction with advanced features of NPWT. Here, some proven benefits of occlusive properties are highlighted. The occlusive feature can increase the penetration and absorption of drugs applied in topical form, such as ointments, powders and creams, which can be beneficial in combination with standard wound dressings and therapies such as NPWT. V.A.C Intensive Instillation Therapy (KCI) is designed to combine instillation therapy with NPWT. Instillation, as defined by the V.A.C Instillation documentation, includes: 1) the introduction and removal of topical solutions in liquid form and 2) the ability to wash and clean a wound using a rigorous irrigation technique. The main complaint of the caregiver about this and other dressings for the purpose of instillation is that liquid usually leaks during the instillation process, especially during a rigorous irrigation procedure that, in addition, induces air leaks during the continuation of treatment. The seal and the occlusive dressings disclosed
23/49 in this document solve all leakage problems that may arise. Normally, the irrigation process has leaks due to propagation cracks in the dressing, eliminating these cracks, the sealant and the dressing techniques in this disclosure significantly reduce the potential for leaks and the formation of leaks during instillation. The port (s) required for the insertion and removal of the instillation fluid can be connected directly to the occlusive dressing incorporations disclosed with the same tube-dressing connection methods that are disclosed in the Tube-Curative Interface section in this release.
[086] Although the current published occlusive dressings have been developed with the NPWT system in mind, they can be used for any application for which an airtight or waterproof seal is also desirable (also known as airtight and waterproof). water on the skin. Therefore, they are applicable in several fields in addition to NPWT and, more often, in the field of skin sealants and their methods. In fact, occlusive dressings create a volume of control over the tissue area where they are applied, which is a desirable feature for numerous applications, many of which are disclosed in this application document.
[087] The occlusive dressings discussed in this release are the first skin dressings to provide a volume of control, as no other dressings have so far been proven (reliably) to be truly occlusive. This would benefit the improvement of advanced healing treatments that are sensitive to any variation in the environment, such as stem cell therapies, for which complete control of the environment is necessary to achieve deterministic results. If a specific air leak is desirable, its rate can be precisely controlled in the control volume using precision valves. Currently, there is no precise predetermination for the rate of air leakage in any dressing, mainly because most air leaks in dressings vary over time and with body movement. In addition, occlusive dressings can be used in acute in vivo toxicity tests for irritation and skin sensitization. The test animal is scraped and the test material is applied to the skin which is wrapped in an occlusive material. The skin is then exposed after 23 hours and an evaluation is made for redness and edema, this evaluation is repeated after 48 hours.
24/49 [088] FIGURE 1 is a schematic view in expanded perspective of a set of dressings 20 including a curtain 22, a new flange 26 and a tube 24 with a first and a second protective coating 28 and 30, prior to application of a liquid seal according to the present invention. The curtain 22 and the second cover 30 define the holes 32 and 34, respectively, through which the tube 24 is insertable.
[089] FIGURES 2 and 3 illustrate a new first end 40 of tube 24 of FIGURE 1 being inserted through the new symmetrical flange 26 to form a set of tubes 27, FIGURE 3. The first end 40, also referred to as distal end 40 , includes a spiral extension 42 which, in one construction, is formed by making a helical cut at the distal end of the tube 24. In other constructions, a separate component having a helical shape or other geometric shape is fixed to serve as an impediment to clogging of the distal end 40. The spiral extension 42 minimizes possible obstructions of the lumen 46 through the tube 24. Another anti-obstruction construction is shown in FIGURE 4 with a distal end of the tube 60 defining the perforations 62 and 64, the notches 66 and 68 and a blunt tip 70. Perforations 62 and 64 can be formed as cutouts in the form of diamonds, circular holes or other geometries. A notch 44, FIGURE 2, is also created in this construction to further minimize the possibility of lumen 46, through tube 24, becoming blocked, as described in more detail below.
[090] The arrow 48, FIGURE 2, represents the distal end 40 being inserted through the passage 50 in the flange 26, defined by a region of the sleeve 52, a region of rotation 54 and an adhesion region 56 showing an outer edge 57. The glove region 52 is attached to the tube 24, as described in more detail below, in a final location as shown in FIGURE 3. In another construction, the glove region 52 is fixed, by adhesion, welding or other hermetic connection process , to a small piece of pipe with a connector that connects to a longer piece of pipe. In yet another construction, the flange includes an integral connector capable of coupling to the flexible tube as shown in FIGURE 43. The rotation region 54, in this construction, serves as a flexible spherical fitting. As shown in FIGURES 5A and 5B, tube 24 can be manipulated in the direction of arrow 72, FIGURE 5A, to a desired lateral orientation as shown in FIGURE 5B. Lumen 46, through tube 24, in
25/49 some constructions, remains open because the distal end 40 extends beyond the adhesion region 56, with the notch 44, preferably below the glove region 52, but over the adhesion region 56, so that the rotation region 54 does not collapse on itself. In other constructions, the flange is short and wide enough to minimize the possibility of closed compression. In some constructions, the glove 52 region is sealed in an airtight, fluid-impermeable manner, first applying a silicone adhesive, such as the Walker Tape Company's Liquid-Tape adhesive, as mentioned above, to the outer surface of the tube 24 that will be placed in contact with the glove region 52 during assembly. A liquid seal can be applied to the junction of the tube 24 and the flange sleeve region 52 to further occlude a possible fluid leak at that junction.
[091] In some constructions, flange 26 is produced directly on the tube 24, by means of an immersion, molding and spraying process. In constructions where flange 26 is constructed entirely from, or coated with, a material that has an affinity of its own, the glove region 52 can self-adhere to the region of rotation 54 and the region of adhesion 56, insofar as region 56 is exposed, when folded against itself, as shown in FIGURE 5B. When the material forming the exterior of the flange 26 has an affinity for the material of the curtain 22, especially for materials containing latex compounds, the exterior of the glove region 52 will also adhere to the curtain 22, at least to some extent; the latex-like material applied to the surface of the tube 24 will further improve this adhesion. Fixing the tube 24 in a fixed orientation, as shown in FIGURE 5B, can be especially beneficial for patients in bed or with restricted mobility, so that the tube can be positioned to prevent the patient from lying on the tube for long periods or to avoid compromised areas around the wound. In other circumstances, where the tube remains mobile, it can be easily repositioned because the rotation region 54 remains flexible and the tube can be monitored and moved frequently to ensure that the tissue is not degraded due to remaining on the tube in one position for a longer period of time. Especially for active patients, tube 24 can be periodically repositioned by the patient or the healthcare professional.
26/49 [092] FIGURES 6 and 7 show a curtain 22 being covered by a topcoat 30 to produce a dressing in accordance with the present invention. Preferably, the curtain 22 has a thickness ranging from 2 microns to 0.4 mm, especially in the parts that will be applied on the skin; a greater thickness in the central part, to be located on a wound, is less critical for occlusion. In some constructions, the adhesive is pre-applied to the surface facing upwards, shown in FIGURES 6 and 7, which will be put in contact with the skin during use; in other constructions, the adhesive is also placed on the opposite side of the curtain 22, to be covered by the coating 30, as indicated by the arrow 81 in FIGURE 6, for storage and handling. In some constructions, the adhesive is applied as a uniform layer and, in other constructions, as concentric circles or other non-uniform patterns. Preferably, the liner 30 has extensions 82 and 84 that extend beyond the curtain 22 to facilitate handling the dressing without touching any adhesive and to allow easy removal of the liner 30 from the curtain 22 after placement in a patient.
[093] FIGURE 8 shows an orifice 32 drilled in both layers of the dressing of FIGURE 7. Orifice 34, FIGURE 1, is not visible in FIGURE 8.
[094] FIGURES 9 and 10 show a set of tubes 27 being inserted, arrow 90, in the dressing of FIGURE 8 with the region of the adhesive 56 at the edge 57 of the flange 26 being sealed to the curtain 22 using the pre-applied adhesive. Additional adhesives or sealants can be added around edge 57 or pre-applied to region 56, as desired.
[095] FIGURE 11 shows a protective coating 28 being added to the dressing 20 of FIGURE 10. The protective coating 28 protects the adhesive on the side of the skin, when pre-applied, until the coating 28 is removed, as shown in FIGURE 16 , below. The distal end 40 with the anti-clog feature 42 is sufficiently loose and short in length to be contained under the coating 28. The coating 28 preferably extends beyond the curtain 22 over regions 82 and 84 of the coating 30.
[096] FIGURE 12 illustrates how a user can cut the dressing 20 of FIGURE 11, along the dashed line 92, for example, using scissors 93, to fit a wound.
27/49 [097] FIGURE 13 shows a handling tab 94 being added, arrow 96, to dressing 20 of FIGURE 12, which is especially useful if the covering extensions 82 and 84 are cut. In this construction, flap 94 is attached by adhesive 95 to one of the liners 28 and 30 to assist in removing the chosen liner. Additionally, or as an alternative, perforations 97 and 98 create locations to facilitate the removal of coatings. If perforations are used, it is preferable that the top and bottom coatings have perforations aligned at different angles. The preferred angle difference is significantly perpendicular, that is, a distance of about ninety degrees. Perforations are preferred when extensions 82, 84 are not provided. Dressings are difficult to handle with surgical gloves, necessary for sterility. Therefore, the handling tabs eliminate the need for the clinician to touch the adhesive. This is also desirable since powder gloves tend to cause the adhesive to stick to the powder and lose its adhesion properties. Another solution would be to provide nonstick protectors for hands or fingers, as shown in FIGURES 24 and 25, similar to the applicator where the sealant is applied with the fingers shown in FIGURE 20. This is especially important when the dressings are reshaped, potentially removing the characteristics handling, and when the user is removing the top protective liner and folding the top folds. Ideally, additional handling components are incorporated into packaging components or protective coatings. For example, the package the curtain is in turns from inside to outside to form a sterile handling glove, or the bottom liner is used to maneuver the highest level of adhesive interactions when dealing with the top liner. The bottom coating may have a glove cutout (pre-perforated), FIGURE 24, as the non-stick side, for example, coated with silicone, initially facing the adhesive; preferably, a non-stick coating is provided on both sides for application with both the right and the left hand.
[098] FIGURES 14 and 15 illustrate the debridement of an open wound W and the cleaning of the wound cavity and the surrounding skin SK, preferably at least 3 cm in width, as indicated by dashed line 102, with standard cleaning methods , such as alcohol and gauze wipes. Typically, the next step is to plug the open wound W with fluid-permeable material 104, such as gauze, open cell foam or a sponge.
28/49 [099] FIGURE 16 is a perspective view of the underside of dressing 20 of FIGURE 11 with the liner 28 being removed as indicated by arrow 106, for example, pulling on corner 108 to expose curtain 22 with the adhesive pre-applied.
[0100] FIGURE 17 is a schematic top plan view of a dressing 20 according to the present invention attached to the SK skin via an adhesive curtain 22 around the wound. When negative pressure treatment is desired, a source of negative pressure is connected to the tube 24 so that its lumen is in communication with the wound cavity.
[0101] FIGURE 18 is a schematic perspective view of the dressing 20 of FIGURE 17 with the upper protective liner 30 being removed, as indicated by arrow 110. Dashed line 112 represents a perforation or pre-cut line to aid removal the coating 30 without sliding it over the tube 24.
[0102] FIGURE 19 shows the liquid seal 114 being applied to the edges of curtain 22 of FIGURE 18. The preferred seal incorporation has a width of 2-3 cm and is centered on the edge of curtain 22.
[0103] If the dressing is applied to the contoured surfaces of the body, as described below in relation to FIGURES 29-30A, folds in the flat dressing may be necessary to adhere to the skin surface in order to adapt to the surface contour. These folds generally move from the outer edge towards tube 24. In this situation, the preferred method of application is to minimize the number of folds by creating some larger folds. Preferably, there are no more than four folds, divided evenly around the periphery of the tube 24. These folds are created by adhering the curtain to the surface of the skin, forming a "T". Then, when the upper protective covering is removed, the folds are adhered to the surface of the curtain with the adhesive on the top of the curtain. Preferably, the folds form individual triangles on the top surface of the curtain. The folds are then pressed to remain flat and completely adhered to the surface of the curtain. The seal is then applied to the edge of each fold to seal the area between the fold and the top of the curtain from the surrounding environment. This additional seal preferably connects to the seal placed around the outer edge 114, FIGURE 19, for example. Preferably, the additional sealant is applied significantly at the same time as the sealant
29/49 original with the same sealing material. Any curtain material that extends over the skin, in addition to the original curtain edge, when folded, is preferably cut before pressing the folded curtain material against the skin to remain within the original curtain edge. Patterns can be provided on the top protective liner to guide the user where to place the folds, when necessary.
[0104] FIGURES 19A and 19B illustrate the modification of the dressing cover 20a according to the present invention, with curtain 22a, tube 24a and flange 26a. If dressing 20a is too small to cover the desired skin area around the wound, preferably 3-5 cm, for example, if the user cuts the dressing a lot, as shown by cutout 120, when remodeling the curtain to a easier application, or to avoid a complex contour close to the wound cavity, the user can use sealant to reconstruct the dressing, as shown by the additional seal 122, FIGURE 19B. In this way, a modified occlusive dressing 20a is obtained. However, it is preferable that the curtain 22a itself covers the entire wound edge to protect the wound cavity from the sealing material.
[0105] FIGURE 20 is an expanded schematic view of a sealant bottle 130, with occlusion wefts 131 for receiving a lid 134, with a nonstick finger protector 132, shown in cross-section, preferably with an edge 133, optionally positioned inside vial 130 for storage and transportation.
[0106] FIGURES 21A and 21B show a dispensing apparatus 140 with removable cartridge 150 of liquid seal. The dispensing apparatus 140 has a trigger 142 and a nozzle 144 in its construction and can be powered by a cylinder of compressed gas, such as a CO2 cartridge, contained within a compartment 146. Preferably, the apparatus is powered by gravity . Since it does not have to be a needle valve, as found in typical air guns to stop the flow of a fluid, an adhesive flap 152, FIGURE 22, is initially removed from tip 154 and cartridge 150 is inserted into apparatus 140 as represented by arrow 149, FIGURE 21B. A plug 156, FIGURE 22, is then removed, for example, by twisting, to expose an air hole in the upper part of the cartridge 150 and to activate the apparatus 140 and to allow the seal to flow, that is, sprayed out of the nozzle 144. Apparatus 140 can be
30/49 temporarily left aside, between the application of the sealant layers, with the nozzle 144 facing upwards.
[0107] FIGURE 22 is an enlarged perspective view of the cartridge of FIGURES 21A and 21B with internal chamber 160, raised floor 162 and inclination 164 in this construction to assist gravity feeding of the sealing liquid to tip 154, as indicated by the arrow 166. In other constructions, a multi-component seal is delivered using a separate chamber for each component. The components are mixed during delivery in a downstream mixing chamber or in a mixing nozzle, for example, 3M ™ Scotch-Weld ™ EPX ™ Mixing Nozzle, currently available from 3M Company, ST. Paul, Minnesota. Other multicomponent delivery systems can be used, such as those marketed by Henkel Loctite Corporation, Rocky Hill, Connecticut. One or more components of the seal may be a powder or other state, provided that the final seal is delivered in a liquid state, including liquid droplets via shear or a propellant.
[0108] FIGURE 23A is a schematic perspective view of a manual compression applicator 170 for liquid seals.
[0109] FIGURES 23B and 23C are enlarged views of the squeegee-type outlet 172 with and without a removable strip 174 that covers the distribution openings 176 of the passages 178 that communicate with the inner chamber 180. In this construction, a removable flap 182 , FIGURE 23A, allows air to enter chamber 180 during delivery of the seal.
[0110] FIGURES 24 and 25 are schematic top plan views showing non-stick gloves 191 and finger protectors 201, formed in coatings 190 and 200, respectively. These applicators are non-stick, for example, a non-stick silicone coating, on only one side in some constructions and, in other constructions, they are non-stick on both sides.
[0111] FIGURES 26-28 are schematic top plan views of coatings 210, 220 and 230 with indicator lines 212 and 214, 222 and 224, and 232 and 234, respectively, with different formats for selected locations and outlines of a patient . The shorter lines 222 and 234 have priority if folds are required, a symmetrical shape, such as a square or circular shape of the liner 210, FIGURE 26, has fold lines of equal priority.
/ 49 [0112] FIGURE 29 is a schematic side view of a dressing 20b according to the present invention being applied to an H heel of a foot F. The flange 26b is positioned with the tube 24b which communicates with a wound in the heel H. A large fold 240 with edges 244 and 246 is shown.
[0113] FIGURES 30 and 30A are enlarged schematic views of the dressing in FIGURE 29 with a fold 240 being created and then flattened to improve the fit to the heel. All edges 242, 244 and 246 must be sealed with seal 248 according to the present invention.
[0114] There are several different methods for using the sealant described in that disclosure in the dressing-skin interface. The first method is to use the sealant in conjunction with current commercial skin dressings (or dressings with similar incorporations) to achieve occlusive properties. To do this, the dressing is first applied to the skin, step 1502, FIGURE 33, then the wound is covered, step 1501; generally, the dressing (also known as a curtain component) is shaped like a flat adhesive tape. The drainage tube can enter the dressing at the dressing-skin interface, or it can have its own connector that requires an incision in the dressing, above the wound cavity, step 1503. The dressing system is applied with your recommended procedure. Next, all dressing-skin interfaces are sealed with the sealant and potentially additional adhesive, step 1504.
[0115] At the dressing-skin interface, the contact of the sealant with the skin must be biocompatible. The sealant must fit and seal the folds and creases in the skin, which are usually interconnected when a standard, flat dressing is applied. These cracks are an important source of air leaks within the system without a liquid seal with suitable wetting properties. The proper wetting properties are achieved by applying the liquid sealant directly to the skin and the dressing in its liquid form through a painting process or by spraying the liquid with an atomization process that eliminates the flow of the liquid and which can result in a more uniform thin film.
[0116] Once there is a crack in the flat dressing, crack propagation can occur in tension and compression with the application of reduced efforts. Therefore, it is desirable to seal any initial cracks in the dressing-skin interface. Furthermore, adequate sealing at the dressing-skin interface at the dressing edge prevents any air leakage from future crack propagation, a
32/49 since the seal prevents the spread from reaching the external environment. If an additional adhesive is used between the sealant and the dressing-skin interface, then the adhesive must adhere to the skin, the dressing and the sealant to form the necessary bonding force. The adhesive, or its applied components, must also adjust to folds and creases in the skin and / or dressing. The adhesive must be compatible with the skin, dressing and sealant when applying the adhesive under the sealant, or when mixing the sealant with a component of the adhesive before application.
[0117] The use of liquid sealant may allow the elimination of current commercial dressings (or incorporations of similar dressings, also known as the curtain component). The liquid sealant can be applied directly to the wound cavity and wound dressing material. In some embodiments, the buffer material may require an additional liquid-proof barrier if the liquid seal can be absorbed by the buffer material. In addition, it may be necessary to have a liquid-proof barrier at the interface between the tampon material and the wound edge, since the seal can potentially leak into that barrier, depending on the tampon material application technique, which can be undesirable. An opening at the interface between the tampon material and the wound edge may be detrimental to the sealant in creating a continuous occlusive film, or the potential for the sealant to come into contact with the internal tissue of the wound cavity may need to be eliminated. These barriers can be of an occlusive nature; in that case, the sealant must be applied to any of its non-occlusive margins; however, the sealant can also cover the entire surface area, which can help to maintain the adhesion of the barriers. The barriers can be made of countless materials, for example, from polymeric adhesive and non-adhesive films to clays and glues. The barriers mentioned in this description are different from standard dressings, since the adhesion of standard dressings to the skin forms the structure and adhesion integrity of the dressing-skin interface, and the barriers currently discussed are used to protect the wound from the sealing component and they are not necessarily intended to provide any structural support beyond that purpose.
[0118] Skin maceration under a truly occlusive dressing can be a concern for the caregiver. This can be solved by selecting the material, as a single path, occlusive sealing material can be used
Directional 33/49 to allow the skin to breathe and its moisture to evaporate without allowing air to enter the system. Similar material properties are now commonly found in materials used for sportswear. In addition, this fact can be resolved from a project perspective. The area of application of the sealant can be made narrow enough that the moisture of the fabric under the dressing can diffuse around the seal. If a larger surface area is required for sealant adhesion, a sealant web can be applied to allow diffusion around the strip. In addition, the sealant can vary in thickness through the atomization process, where a dressing thick enough for the occlusive properties is sprayed around the edge of the wound or at the dressing-skin interface. This application can maintain a narrow width, and then the rest of the dressing can be made in a thinner, breathable layer, based on a different number of lamination layers or using different variables and spraying techniques. This thinner part of the dressing can maintain a continuous film incorporation with the occlusive barrier, since the detachment energy of the thinner part is significantly reduced due to the reduction in thickness, increasing the effective bond strength. In addition, this breathable component can be woven onto the surface, rather than an embedding that covers a continuous film.
[0119] The tube-dressing interface must be sealed if the connection is not prefabricated to be occlusive during its manufacturing process, as is the case with the Spiracur dressing. The seal must bond to both materials found at the tube-dressing interface and form an occlusive seal that extends over the interface, step 1504, FIGURE 33. Three methods can be used for that seal interface and its components. 1) dressing components that are not originally prefabricated to be occlusive can be pre-assembled and sealed before applying the dressing (most desirable from a perspective of the reliability of occlusive results); 2) the dressing components can be pre-assembled before applying the dressing, but the sealant is applied after applying the dressing; or 3) the tube connection method is fabricated and sealed to the dressing during or after applying the dressing.
[0120] The first method provides the user with a method to prefabricate a custom dressing that has an occlusive tube-dressing interface. This eliminates many potential air leaks and, for the first time, allows dressings
34/49 personalized, prefabricated and occlusive, be made in a clinical environment. Method two is convenient if the liquid sealant is the same for all dressing interfaces; however, all interfaces (tube-dressing and skin-dressing) can be sealed in one step after applying the dressing. Therefore, this method requires that the pre-assembly configuration be stable during its application, before any sealant is applied. For method three, there is less preparation work to be done by the caregiver. If this sealing method is ergonomic and repetitive without any prefabrication, then this method can significantly reduce the time used to perform the dressing, which is an important saving for people and costs for the service center. Ergonomic and repeatability characteristics depend on the designs of pipe connectors.
[0121] Various tube connector designs can be produced for sealing purposes to be used in all three methods. Three basic design concepts can span many incorporations. The three design concepts are:
[0122] 1) Pierce the dressing with the drain tube, so that the curtain fits comfortably against the tube. Then apply the sealant to the tube-dressing interface. With this method, the tube can be lowered into the wound cavity to a usual length, as indicated by distal end 1801, FIGURE 36. If the sealant's adhesion force needs to be increased, an additional adhesive can be added under the sealant, or mixed with the sealant, or the tube and / or dressing can be pre-coated with a material with which the sealant has an affinity. In practice, rubber polymers generally have a strong affinity for themselves, even if the bottom layer is cured. Multiple drainage holes are preferred, as shown in FIGURE 4, or a spiral-cut pattern, FIGURES 2 and 3, in the part of the tube that extends in the dressing, in order to prevent the tube from occlusion against the saturated buffer material or of the particles in the wound exudate.
[0123] 2) The same concept as in concept 1, except with a different tube that enters the dressing. This concept is for the case where an initially flat dressing is used. Two pieces of the flat dressing cover the wound from two different sides and they are located above the wound cavity in a "T" joint. The tube is placed through this “T” joint in the wound cavity before
35/49 the “T” gasket is sealed. Then, all interfaces are sealed with the liquid seal.
[0124] 3) The same concept as concept 1, except at the tube-dressing interface, a prefabricated base 1802, FIGURE 36, here also referred to as a flange, is attached (preferably hermetically) to the tube to provide a flat surface to seal the dressing. In a functional embodiment, the base 1802 is made of a flexible material for which the seal has a strong affinity and there is no need for any other adhesive. The base material can be reduced in thickness, in order to tune to join its edge (s) to the dressing, which may be more desirable for a reliable application of the occlusive sealant. The tube can connect to base 1802 in many orientations; however, it is generally preferable to minimize the dressing profile. However, normally when minimizing the profile of the dressing, the tube is in an orientation that cannot be readjusted after applying the dressing. Therefore, the tube can connect perpendicularly to the skin surface and, using an upright tube and / or the flexibility of the 1802 base material, allow the tube to be oriented in any orientation after applying the dressing, in such a way that the tube is not bent and does not block itself. For this concept, the tube may not pierce the curtain, but the hole (also known as an incision) may be pre-cut instead; the base may extend beyond the orifice (also known as the incision).
[0125] 4) The fourth concept is similar to concept 3, except that the tube does not extend into the wound cavity, FIGURE 37. However, an incision is made in the dressing and the tube opening is positioned over the center incision, as in the TRAC Pad The base must extend beyond the incision and be sealed to the dressing with liquid sealant or occlusively pre-sealed during manufacture. In this incorporation, the end of the tube must be designed to interrupt a potential occlusion in the base, in the tampon materials or with the substances from the wound exudate. Therefore, if the base is connected to the tube above the surface of the skin, the end of the tube may have a spiral cut along its length, up to its interface (intersection of the upper part of the base 1802 with the distal end of the tube 1901 at FIGURE 37) with the base. In addition, an anti-clogging material can be placed at the end of the tube, between the base and the dressing. This anti-clogging material can be an open cell sponge with large pores.
36/49 [0126] In the tube-dressing connection, with all interfaces sealed, an adhesive can be added if the bond strength needs to be increased. The base can also be initially attached, with tape or adhesive, to the dressing before applying the sealant. Tube connectors can exist in many embodiments similar to those listed above; however, a limited number of examples are given here to illustrate the basic connections and occlusive dressings. The tube-dressing interface can be occlusively pre-sealed during manufacture. In addition, the component attached to the interface can only comprise a pipe connector (which may or may not contain a pipe segment) which is additionally attached to a longer piece of pipe which then connects to the pump. Examples of occlusive pipe connectors are hook connectors, which connect directly to the pipe, specific connectors that join together and are required at each end of the connected components, and a compression adjustment seal, such as a cylindrical hole. rubber, in which the tube can be occlusively pressed.
[0127] As previously stated, handling a bandage when incorporating flat tape can cause the adhesive to weaken before applying the adhesive. Therefore, specific handling devices for the caregiver can be added to the curative component. Such devices may include non-stick gloves, such as, for example, PTFE gloves, FIGURE 24, or non-stick tips, FIGURES 20 and 25. The handling tabs that extend from the dressing can also be incorporated into the dressing design. These tabs can be a part of the dressing (also known as a curtain) that are torn after applying the dressing, or they can be extensions of a removable support material that is attached to the dressing as shown in FIGURE 13.
[0128] For the application of the sealant, many incorporations and application methods are possible. For mechanical applications, including painted applications, the applicator incorporation can be a brush, roller, sponge, spatula or other similar incorporation to apply paint in a "spread" way. These spreading devices can be attached to the container (preferably refillable) of the liquid seal for continuous feeding of the seal to the applicator; it can be gravity fed (passively or controlled by the user), or the applicator can be prepared with the sealant by immersing the applicator in the sealant container. Although painting is not the method of application
37/49 preferred for the liquid dressing, it may be preferred if a high viscosity sealing material is used to cover large gaps, for example, between the tampon material and the wound edge, the potentially high edges of a hydrocolloid in its skin interface, or large creases, gaps and folds in a hydrocolloid dressing, due to its high rigidity and thickness and geometric incompatibility.
[0129] For sprayed applications, the device for atomizing the seal with a shear process can be a spray gun or airbrush, refillable, with an external source of compressed gas, or this feature can be incorporated into a portable spray, miniature that can be refilled and refilled. Each incorporation has a specific design package for pressure, velocity and gas flow that is necessary to shear the seal, in order to form a continuous thin film layer on the skin. If the operation is outside the package, the spray droplets may be very large and may not spray as a continuous layer, but will eject on the skin, or the gas may not shear the fluid out of the fluid opening. In a functional embodiment, the liquid seal is fed by gravity into a central opening in a nozzle and the compressed gas shears the seal through a circular ring around the opening in the seal nozzle. There may be several nozzles for one or both fluids. In particular, the spray pattern can be controlled by shearing the seal from multiple gas ports pointed in different shear directions through the liquid seal nozzle. In a portable device, compressed gas can be generated from a miniature gas cylinder, for example, a high-pressure liquid carbon dioxide cartridge. The spraying device can be loaded by the caregiver when the gas-loaded tube is activated.
[0130] Once the dressing-skin and dressing-tube interfaces are sealed (both during the application of the dressing and during its manufacture), the caregiver must monitor the pump to ensure that there is no air leakage in the system above a pre- determined, usually zero, step 1505, FIGURE 33. This can be done visually, for example, by monitoring the expansion of the pump (also known as a mechanical pump) or with an air leak test that is disclosed below in the pump descriptions , or can be detected using pressure sensors to detect vacuum pressure over time (especially with
38/49 a mechanical pump if the pressure changes continuously with the internal volume of the pump). If the air leak is too high, the dressing-skin and / or dressing-tube interfaces can be resealed with the liquid sealant, removing the previously applied sealant material, or overlapping the new sealant over the previously applied sealant material, step 1506, FIGURE 33. This is an iterative process until the desired air leak limit is reached, step 1507.
[0131] When a truly occlusive dressing for NPWT is used, the behavior of the system changes from an active flow system, FIGURE 34A, to a passive flow system 1602, FIGURE 34B. When air escapes, arrow 1603, FIGURE 34A, in an active system, the system has an active flow of fluid (air and wound exudate) that both removes exudate from the wound cavity 1604 and tends to dry the wound cavity. With an airtight system 1602, FIGURE 34B, the flow of exudate towards the pump is no longer an active flow, but tends to increase, 1605, even inside the tube over time, maintaining a passive flow to the vacuum source . A pressure differential still exists on the surface of the wound bed 1606 and, thus, negative pressure continues to be applied to the wound bed; however, the volume of wound cavity 1604 fills with exudate fluid 1605 over time. This feature can increase healing benefits compared to standard NPWT, as it maintains moisture, the healing environment at the wound site, while also maintaining the benefits of vacuum pressure for NPWT.
[0132] · With this increase in fluid 1605, FIGURES 34B and 35, the adhesion of the dressing-skin interface 1607 can be compromised by the exudate over time and the exudate can eventually damage the dressing and leak out of the dressing interface -skin. The rate of exudate removal, the size of the wound cavity and the time between dressing changes determine the accumulation characteristics. If the possibility of compromising the dressing exists, it can be avoided with several methods, including:
[0133] 1) An additional sealant or adhesive can be applied that can resist the accumulation of exudate. For this case, the sealant and / or the additional adhesive should be applied as close as possible to the wound edge. This is difficult if a standard dressing was used. Flat dressings usually leak over a three-day dressing period if fluid build-up occurs. This is because the exudate normally degrades the adhesive, spoiling the dressing at the edge of the wound.
39/49 in the places of the initial creases in the dressing. Therefore, a dressing without initial cracking at the wound edge is preferred; however, the application of the dressing described in the previous section only seals the outer edge of the dressing. To solve this problem, a flexible adhesive, with adhesive properties and flexibility, such as a +30 days silicone glue for wigs, can initially be applied to the wound edge under the flat adhesive dressing. It can fill in any initial cracks at the edge of the wound and prevent degradation caused by the exudate. [0134] 2) A barrier can be applied to the edge of the wound after insertion of the wound dressing material. This barrier can be made of highly absorbent material, in order to reduce the chance of spilling exudate due to factors such as gravitational effects.
[0135] 3) The end of the tube can be lowered into the wound cavity, below the plane of the skin surface 1702, as indicated by arrow 1701, FIGURE 35. Therefore, the fluid drain line 1703 and, therefore, the accumulation of exudate will not increase until wound edge 1607, degrading the adhesive. This technique may be possible if the wound is superficial.
[0136] 4) A bleed valve can be incorporated in the curative system to allow a temporary, controlled air leak in the curative system to clean the fluid. This valve can be incorporated using the same connection methods described in the Tube-Curative Interface section in this disclosure. This can cause the fluid to actively flow into the fluid collection tube during the initial pressure drop in the system. If necessary, the pump can be restarted.
[0137] 5) The wound buffer material can be made of materials with low resistance to exudate flow and low absorption, which would encourage the fluid to passively move through the system at a faster rate on a more direct path towards the drain pipe. Depending on the rate of exudate removal, this may not solve the problem if the rate is very low. In this case, the tampon material should be designed to direct the flow towards the drainage tube and, specifically, away from the wound edge.
[0138] 6) If the dressing is completely manufactured out of the liquid sealant (potentially with an additional adhesive), without any flat dressing components, then there will be no crack at the edge of the wound when properly applied and therefore there will be no initial crack so that the exudate deteriorates.
40/49 [0139] Although in this disclosure any mechanical or electrical vacuum source can be applied to occlusive dressings, a mechanical system may be preferred due to the significant benefits over electric pumps. Mechanical vacuum pumps and methods are provided for medical application in the treatment of negative pressure wounds (NPWT) that must be compatible with the disclosed dressings. Some known pumps are described by the present inventor in Development of a Simplified Negative Pressure Wound Device presented in 2007 for his Master of Science in Mechanical Engineering at the Massachusetts Institute of Technology. The pump is initially adjusted and then governed by a linear and non-linear spring force. The pump compartment can act as a collection chamber; however, there may be a separate collection chamber in series with the pump.
[0140] In an embodiment, the pump is a plastic bellows, shown in FIGURE 31, where the housing and the spring can be the same component. The pump is manually compressed and then attached to the dressing tube. A negative pressure is applied by expanding the bellows due to the material characteristics and the spring design. The pressure gradient of the device decreases continuously during the expansion of the standard bellows due to its linear properties similar to that of the spring. In relation to the above description, one skilled in the art may perceive that there are other embodiments: the device may be constructed of a material other than bellows and / or the device may contain an additional spring 5 in parallel with the bellows in order to vary the constant without changing the material properties and the bellows design itself. If there are no air leaks in the system, then the bellows can remain at a constant extent of expansion and therefore at constant pressure. The bellows can be collapsed at any desired treatment pressure, from maximum compression to zero.
[0141] In addition to the standard bellows, another bellows incorporation can resemble a constant force spring to reduce the pressure gradient. In an embodiment of this project, the bellows resembles a long tube that, when completely compressed, is wrapped around itself, just like a measuring tape, as shown in FIGURE 32. As it unfolds and expands from its cross section from flat to open, negative pressure is created in the tube to which it is connected. For the tube to unfold after the expansion of the bellows, the constant of the bellows spring must be greater than the constant of the spring of the uncoiling of the spring at constant force. The unwinding can also be mechanically damped, for example, by adhesion, or forced to unwind after expansion by structural limiters. In this incorporation, a long cylindrical tube can replace the bellows, since it has similar characteristics.
[0142] In all pumps described above, the orientation of the device is independent of the magnitude of the negative pressure pulled and the proper operation of the device. Therefore, the device is highly transportable. In relation to the above descriptions, one skilled in the art may notice that there are other embodiments; however, only selected incorporations are described in detail. To change the pressures in a pump design, separate pumps can be made with materials of different properties and / or dimensions, or the components can be exchanged for different pressure results.
[0143] The negative pressure generated is governed by the material and mechanical properties of the container and / or balloon and by the spring constant. Using a non-constant force spring (for example, a common linear spring 5, FIGURE
31), the pump can be used for negative pressure wound treatments that do not require constant specific pressure (in cases where the internal volume of the pump is expected to expand), although the variation in pressure can be reduced by selecting the appropriate material and design. Using a constant force spring with a constant area, a constant vacuum pressure can be pulled throughout the treatment, even if there is a change in the internal volume of the pump. This is the basis for the design of the folding bellows (FIGURE
32), and the syringe concept discussed in the next section. In addition, a more constant pressure can be achieved by expanding the pump with a non-constant force spring projecting the force / area ratio to be constant, as in a balloon design with a small (constant) diameter in relation to the length and a bellows with a variable cross-sectional area. In addition, constant pressure can be achieved over time if there is no air leakage in the system that causes geometric changes in the pump configuration. In this case, the pumps must be made of materials that do not degrade with the prolonged application of a negative pressure, because of properties such as, for example, relaxation to stress.
[0144] The pump is initially adjusted and then governed by gravity. This includes an expansion vessel that expands due to an applied force,
42/49 for example, a weight. The pump compartment can act as a collection chamber; however, there may be a separate collection chamber in series with the pump. In one embodiment, the pump includes a syringe with a diaphragm that coils (similar to an air cylinder with a friction-free diaphragm). The amplitude of the negative pressure is governed by the diameter of the syringe and the magnitude of the fixed weight. A specialist can see that a similar device can also be constructed from any piston-sealed syringe. In relation to the above descriptions, the device can also include a linear spring in parallel with the syringe or a constant force spring in series with the syringe for expansion, eliminating the need for weight. This incorporation would then fall into the spring-driven pumps described in the previous section. A winding diaphragm can also be achieved using a rubber ball design. One hemisphere of the rubber ball is held rigid in its inflated position, for example, connecting it to the inside of a rigid hemisphere, and the other hemisphere is compressed. The incorporation of the pump resembles a bowl. Then, the bowl is oriented so that its hollow side faces downwards. A weight is hung from the ball (ie, a rubber ball) inside the hollow interior of the hemisphere and the wound drain tube is connected to the internal volume of the pump (preferably through the upper part of the rigid hemisphere). The weight pulls a negative pressure as the ball returns to the shape of a sphere.
[0145] Another incorporation for a gravity-driven pump is created by a siphon. The pump compartment can act as a collection chamber; however, there may be a separate collection chamber in series with the pump. The pulled pressure is equal to:
rho * g * h (2) where rho is the density of the fluid in the column, g is the gravitational constant and h is the height of the column. The fluid must be compatible with the wound (for example, saline), unless a control valve is used to ensure separation of the pump fluid from the wound cavity. The pump can be configured in two ways, depending on the patient's situation and the desired pressure:
[0146] 1. The pump can include a column of fluid in a tube directly connected to the wound. The lower fluid container (preferably closed, expandable) can remain at the desired height in a separate mechanism (such as a hanger or the floor) or can be attached to the lower end
43/49 patient's discharge, again at the desired height. The diameter of the tube determines the pressure gradient: the larger the diameter, the smaller the pressure gradient as the fluid is collected.
[0147] 2. The pump can include two sets of fluid with a tube from the highest fluid set for the wound. The patient's mobility would be determined by the length of the tube and the mechanism used to transport the pump (for example, a mobile support can be used). The diameter of the highest container determines the pressure gradient: the larger the diameter, the lower the pressure gradient as the fluid is collected.
[0148] Integrating spring-driven pumps with the gravity-driven concept allows for greater performance. Therefore, the magnitude of negative pressure that a spring-driven pump can achieve is not completely limited by the material properties of the container, the design and the combination of the spring constant. Additional weights can be attached to one end of the pump in series with the spring in order to pull a higher negative pressure. (For the balloon concept, parts of the balloon may require structural support, so that the balloon does not collapse on itself as the weight acts on it). Weights can be fixed between the pump and the floor. Even in this form, the orientation of the pump must be maintained, varying the additional weight is a simple solution to achieve several pressures in addition to those original to the pump.
[0149] A container evacuation pump is not continuously governed by a force exerted on the container. On the contrary, the pump is simply a rigid evacuated chamber that is continuously monitored by means of a pressure gauge, for example, gauge 4 in FIGURES 31 and 32. Alternatively, a mechanical control gauge, with an ideal interval of pressure. When the vacuum pressure drops to a predetermined level, the notification mechanism is activated and the rigid chamber is reloaded. The refill can be by a pump or by human suction. In this embodiment, the rigid chamber can act as the collection container, or a separate, expandable and non-structural container, can be inserted into the rigid chamber that is directly connected to the wound drainage tube. An expandable collection chamber can be integrated with any of the mechanical pump concepts disclosed in this document, to collect fluid into the pump body, acting as a collection liner instead of a separate collection tube.
44/49 [0150] To administer the NPWT, the pump is connected to the wound drain tube and the container and then evacuated. Air leaks and wound drainage rate determine the pressure gradient and the pressure range is determined by the maximum pressure pumped and the refill notification pressure. The maximum pressure pumped can be limited by an activated pressure inlet valve.
[0151] Since it applies to all the pumps mentioned above, a sequence of steps must be followed. First, the tube connected directly to the dressing should be clipped between the dressing and the collection chamber, preferably at the end of the collection chamber. Then the pump and the collection chamber must be disconnected. If necessary, the collection chamber must be emptied and / or appropriate sterilization procedures must be performed; component 8, FIGURE 31, represents a rubber plug, not shown because an integral floor 260 was used instead to increase access to the interior of the collection chamber in an alternative construction. The pump must then be restarted and the pump and collection chamber reconnected to the tube. Remove the clamp to restart the NPWT. If a dressing change is also desired, it is not necessary to use a clamp to keep the dressing sealed. Also, if the collection chamber does not need to be emptied and / or sterilized, then the tube should be stapled between the dressing and the pump, preferably after the collection chamber, if it is separated from the pump at the end of the pump tube. .
[0152] An air leak test can be incorporated in mechanical pumps, except for the first (1) siphon concept. In the second (2) siphon concept, the highest container is turned upside down for the initial air leak test. Most air leaks originate at the dressing interfaces. In a purely mechanical pump, air leaks fill the limited volume, reducing the maximum time between pump restarts. To eliminate these air leaks and create repeatable and reliable treatment, devices in accordance with the present disclosure may include an air leak test. Using the air leak test, purely mechanical pumps have proven to be able to last the recommended period of time between dressing changes (3 days). However, this test is not necessary for the occlusive seals and dressings disclosed in this disclosure, but can provide visual confidence to the caregiver and the
45/49 patient that the dressing was applied properly and that there are no major leaks in the system.
[0153] The air leak test is in the collection chamber. The tube from the wound that enters the collection chamber enters a solution compatible with the wound (for example, saline). When applying NPWT, someone must confirm that the end of the tube is submerged in the solution and should check the solution for air bubbles B, FIGURES 31 and 32, (any air that initially exists in the tube can create air bubbles, therefore , wait about 1-2 seconds for other air bubbles). If the presence of air bubbles is detected, the dressing must be sealed until the bubbles are no longer detected. This new seal can serve to completely repair the wound, to smooth air leaks in the current dressing or to reinforce the current dressing with other dressing components. Since air bubbles are no longer detected, the pump may need to be restarted depending on how much air has entered the pump.
[0154] A safety feature of the collection chamber is to limit the amount of liquid capable of being collected. If the liquid collected was blood due to the destruction of a vein or artery, there is a possibility that the patient may die from a fatal hemorrhage. The collection chamber should be limited to less than 300 cc of liquid to keep the patient in a safe range from possible bleeding. Therefore, if the design of the pump can draw more than 300 cc of fluid, a safety device must be implemented. If the pump acts as the collection chamber, the safety device must limit its expansion volume. This can be done in several ways through the introduction of structural limiting components (FIGURE 31, component 6) and / or external (FIGURE 31, component 7). If an external collection chamber exists, then the safety feature must stop the negative pressure after collecting 300 cc. This can be done by “capping” the system with a mechanism, for example, a check valve.
[0155] Before a truly occlusive dressing, a benefit of the external collection chamber was that the pump could be larger than 300 cc and therefore account for more air leaks in the system. However, with a truly occlusive dressing, the benefits include that the external collection chamber, with its fluids, can be easily removed for laboratory testing purposes, and the pump requires less stringent cleaning procedures between
46/49 dressing changes. However, these benefits are more quickly resolved with a container of specific volume, not rigid, with no initial volume of fluid that can contaminate a sample of exudate, if desired, and that can be inserted into any of the mechanical pump concepts disclosed in that disclosure in order to collect the fluid inside the pump body, acting as a collection liner instead of a completely separate collection tube. The 300 cc limitation is recommended for an average adult, however, the limitation volume may vary based on the patient. This volume variation can be designed in various sizes of pump or collection chamber or in an adjustable single limit pump or collection chamber.
[0156] Another safety feature of the pump is a single direction valve built into the tube between the wound and the collection chamber, such as component 2, FIGURES 31 and 32. This mechanism ensures that the fluid coming from the pump and the collection chamber does not return to the dressing. It can also be used as the stapling mechanism to restart the pump or empty the collection chamber, depending on placement in the tube. This mechanism can also be incorporated into the tube connector in the collection chamber.
[0157] Another mechanism that can be included is used to evacuate the initial air found in the system after not detecting air leaks. The current method is to clip the pipe close to the pump and restart the pump until the initial air is evacuated from the system. This can also be done by including a single direction valve incorporated into the tube connector on the pump, such as component 2, FIGURES 31 and 32, and another single direction valve incorporated between the inner pump cavity and the atmosphere, component 3 , shown with a cap C in FIGURE 31. With this design, you can continue to compress (restart) the pump until the desired vacuum is maintained; the system does not need to be disconnected. The one-way valve open to the atmosphere can be capped after treatment has started.
[0158] This mechanism cannot be easily integrated to eliminate the need to restart the pump in the project that includes a rubber balloon, which is inserted into a hole in an airtight container and two siphon pumps. For the balloon design, a connection to the container can be made to incorporate the attachment of a separate pump to the single direction valve and the design of the control valve. This pump can be fixed for the initial filling of the
47/49 balloon and evacuation of the container and then removed between dressing changes. In two siphon concepts, a pump can be attached to evacuate the space above the fluid column, increasing the fluid level to a desired height. The pump can be removed for prolonged treatments, between dressing changes. [0159] An individual sealing component can be plugged by itself to make any occlusive dressing. Alternatively, the seal can be plugged as part of a mechanical kit for NPWT, including a mechanical pump and its pre-fixed components, tube with flexible base and pre-fixed tube connector and an optional one-way valve, adhesive film dressing to cover the tampon material (if necessary), the sealing material in a portable spray container, a wound dressing and skin preparation material (if necessary). In addition, if there is a tape-type adhesive bandage to be handled by the caregiver, then nonstick finger guards can be included to improve adherence results. Dust-free gloves can also be included so that the Van der Waals forces for fixing the seal are not altered due to the dust on the skin surface. One skilled in the art can see that the kit components can be exchanged for their different functional incorporations, discussed above. In addition, additional components can be added or placed in additional kits that are used in typical dressing changes, such as, for example, tools for wound debridement, or other wound treatments, such as medications with their respective introduction ports and (potentially) removal through the dressing, into the wound cavity.
[0160] As many dressing systems are identified in this disclosure, one skilled in the art may realize that the liquid sealing method can be used in combination with any fabric dressing (also known as skin) to create an airtight seal. As many pumps are identified in this disclosure, a person skilled in the art can see that any pump combined with occlusive dressing systems can have similar performance characteristics.
[0161] A technique according to the present invention for constructing an occlusive dressing on a wound includes at least one of (1) dressing the wound with a fluid-permeable material and (2) covering at least part of the wound with a material protector. The method also includes applying, such as spraying,
48/49 an organic material, preferably elastomeric, that is in a liquid state, and is at least partially cross-linked, at least after drying and / or curing, on the buffered material and on the skin around the wound to create an occlusive curtain , as a thin sheet, significantly impervious to fluid transfer, having a first inner surface and a second outer surface. As used here, the term “organic material includes matter in a variety of forms, including carbon atoms, including silicone rubbers. The method includes at least drying and / or curing the elastomeric material within thirty minutes after applying the elastomeric material as a layer.
[0162] FIGURE 38 is a schematic top plan view of the wound shown in FIGURE 14, here with a clean skin area indicated by the dashed line 302 and with the tampon material 304, for example, a gauze or a sponge. In addition, a protective coating material 306 is applied to the wound when the liquid curtain material has sufficiently less viscosity and a longer setting time to be absorbed into the 304 buffer material. Protective material 306 prevents the curtain material liquid seeps into the wound cavity. In some constructions, the protective material 306 is a solid polymeric waterproof or semipermeable sheet that can be used with or without adhesive. In other constructions, the protective material 306 is a clay-like substance that can be molded and buffered on buffer material 304 and around a tube inserted in buffer material 304.
[0163] FIGURE 39 is a view of FIGURE 38 with an orifice 308 cut in the protective cover 306, if an opening in the protective cover 306 has not yet been formed or maintained.
[0164] FIGURE 40 is a view of FIGURE 39 with a set of tubes 27c, with tube 24c and flange 26c, having sleeve 52d, rotation region 54d and adhesion region 56d, placed over hole 308 The tube assembly 27c, in some techniques, is held in position using adhesive and, in other techniques, is held manually in place. In addition, tube 24c can directly pierce protective cover 306, so that cover 306 maintains an airtight seal around tube 24c, potentially with an additional sealing barrier, such as clay or adhesive. In another construction, flange 26c is large enough in diameter to completely cover the wound.
49/49 [0165] FIGURE 41 is a view of FIGURE 40 with the material of the liquid curtain 310 applied over the protective cover 306 and over the surrounding skin SK to cover the area 302 of the skin in order to build a dressing according to the present invention. The material of the liquid curtain 310 is applied by spraying technique or application, such that the material 310 is firmly attached to the SK skin around the wound and covers any protective covering layer 306, if used, as well as to create an airtight seal to the flange 26d. FIGURE 42 is a schematic perspective view of the dressing in FIGURE 41. In other constructions, the curtain is built directly on a tube without using a separate flange.
[0166] FIGURE 43 is a schematic perspective view of a new flange 26d, in accordance with the present invention, with an integral connector 320 having a spike-like hook feature 322 that defines passage 324. The hook-up feature 322 it is insertable inside the end of a tube.
[0167] Although some features of the present invention are shown in some drawings and not in others, it is simply a matter of convenience, since each feature can be combined with any other or all other features in accordance with the invention. Although new fundamental characteristics of the present invention have been shown, described and pointed out, as applied to one or more preferred embodiments, it should be understood that various omissions, substitutions and changes in the shape and details of the devices illustrated, and in their operations, can be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of these elements and / or steps, which perform practically the same function, in practically the same way, obtain the same results being within the scope of the invention. Substitutions for elements from one embodiment described to another are also fully intended and contemplated. It should also be understood that the drawings are not necessarily to scale, but that they are merely of a conceptual nature. Therefore, it is the intention to be limited only as indicated by the scope of the attached claims. Further incorporations will occur for those skilled in the art are within the following claims.

权利要求:
Claims (36)
[1]
1. MODIFICABLE OCCLUSIVE HEATING KIT suitable for occlusively sealing a skin area, characterized by comprising:
a curtain (22, 22a) formed as a thin sheet of an organic material significantly impermeable to fluid transfer and having a first and a second surface;
an interface including at least one between (i) a flexible tube (24, 24a, 24b, 24c) having a first end (40, 60, 1701, 1801, 1901) extending through the curtain (22, 22a) and a second end connectable to a negative pressure source, (ii) at least two pieces of curtain (22, 22a) capable of forming a joint through which a first end (40, 60, 1701, 1801, 1901) of a tube (24, 24a, 24b, 24c) is insertable, (iii) a flange (26, 26a, 26b, 26c, 26d, 1802) connectable to a pipe (24, 24a, 24b, 24c), and / or (iv) a connector tube (320);
a biocompatible adhesive that is at least one of (1) disposed on at least a part of the first curtain surface (22, 22a) and / or (2) capable of making contact with at least a part of at least the first surface of the curtain curtain (22, 22a);
when the kit includes the biocompatible adhesive disposed on at least part of the first curtain surface (22, 22a), the kit still includes at least one removable coating (28, 190, 200, 210, 220, 230) covering at least the biocompatible adhesive on the first curtain surface (22, 22a); and at least one container (130, 150, 170) of at least one sealing component which is a rubber polymer selected from a group comprising latex materials, natural rubbers, bio-rubber, synthetic rubbers, hypoallergenic latex, nitrile rubbers, neoprenes, silicones and polyurethanes, and where the sealant is capable of being delivered as a liquid sealant under pre-selected environmental conditions, the sealant as delivered being at least partially cross-linked, at least after drying and / or curing, and which is capable of at least dry and / or cure within thirty minutes after applying the sealant as a layer (114, 114a) on the edges of the curtain (22, 22a) after the curtain (22, 22a) is applied over the skin area.
Petition 870190066437, of 7/15/2019, p. 15/20
[2]
2/6
KIT according to claim 1, characterized in that the organic material and the seal after drying and / or curing are elastomeric.
[3]
KIT according to claim 1 or 2, characterized in that at least the majority of the curtain (22, 22a) and the seal are each derived from a biocompatible latex compound.
[4]
KIT according to any one of the preceding claims, characterized in that the adhesive is a silicone based adhesive.
[5]
KIT according to any one of the preceding claims, characterized in that (i) biocompatible adhesive is disposed on at least most of the second curtain surface (22, 22a) or (ii) at least one second adhesive is disposed on at least least most of the second curtain surface (22, 22a).
[6]
KIT according to any one of the preceding claims, characterized in that the interface includes at least one of (1) a flange (26, 26a, 26b, 26c, 26d, 1802) which has a central passage (50) through which the first end (40, 60, 1701, 1801, 1901) of a tube (24, 24a, 24b, 24c) is insertable and / or (2) a flange (26, 26a, 26b, 26c, 26d, 1802) which has a central passage (50) which communicates with a connector (320) capable of coupling to the first end (40, 60, 1701, 1801, 1901) of a tube (24, 24a, 24b, 24c).
[7]
KIT according to any one of the preceding claims, characterized in that the kit includes a flexible tube (24, 24a, 24b, 24c), and the first end (40, 60, 1701, 1801, 1901) of the tube (24, 24a , 24b, 24c) include a feature (42, 44, 62, 64, 66, 68) to prevent obstruction of the tube (24, 24a, 24b, 24c).
[8]
KIT according to any one of the preceding claims, characterized in that it also includes a mechanical pump capable of serving as a source of negative pressure.
[9]
KIT according to claim 8, characterized in that the mechanical pump is a bellows-type pump capable of being rolled over itself and then unwound to employ a negative pressure.
[10]
KIT according to any one of the preceding claims, characterized in that at least one container (130, 150, 170) of at least one sealing component is a cartridge (150) removably insertable within a dispensing apparatus (140) .
Petition 870190066437, of 7/15/2019, p. 16/20
3/6
[11]
11. KIT according to any one of the preceding claims, characterized in that the sealant adjusts to high levels of tension pressure reached on the skin surface during large movements of body deformation, including adjusting the deformation tension of approximately 0.45 in tension.
[12]
KIT according to any one of the preceding claims, characterized in that it also includes a bleed valve to allow a temporary, controlled air leak in the curative system (20, 20a, 20b).
[13]
13. KIT according to any one of the preceding claims, characterized in that it also includes a port suitable for at least one insertion and / or removal of at least one fluid and / or medication, the port being able to be connected to the dressing (20, 20a, 20b).
[14]
KIT according to any one of the preceding claims, characterized in that the sealant after drying and / or curing maintains an adhesive bonding strength and adhesive properties by means of Van der Waals forces.
[15]
KIT according to any one of the preceding claims, characterized in that the sealant dries and / or cures by means of an evaporation process.
[16]
16. KIT according to any one of the preceding claims, characterized in that the liquid state of the sealant is a low-viscosity liquid, having the desired wetting characteristics and allowing adjustment to all contact surfaces during the application process, including any folds and / the creases in the skin, so that after its application, no air leakage channel is present at the interface.
[17]
17. METHOD OF CONSTRUCTION OF OCCUITIVE DRESSING on an area of skin with a volume to be sealed, characterized by comprising:
selecting a curtain (22, 22a) formed as a thin sheet of an elastomeric material, significantly impermeable to fluid transfer, and having a first and a second surface;
selecting a biocompatible adhesive that is at least one of (1) disposed on at least part of the first curtain surface (22, 22a) and / or (2) applied to at least one of (i) the skin (SK) around the wound (W) and / or (ii) at least a part of at least the first surface of the curtain (22, 22a);
when the biocompatible adhesive is disposed on at least a part of the first curtain surface (22, 22a), still include removing at least
Petition 870190066437, of 7/15/2019, p. 17/20
4/6 minus a removable coating (28, 190, 200, 210, 220, 230) covering at least the biocompatible adhesive on the first surface of the curtain (22, 22a);
placing the curtain (22, 22a) on the skin around the volume to be sealed;
removing at least one removable liner (30, 190, 200, 210, 220, 230), if any, covering at least a portion of the second curtain surface (22, 22a);
application of a sealant that is in liquid state when applied, the sealant being at least partially cross-linked at least after drying and / or curing, on at least the edges of the curtain (22, 22a) and on the skin adjacent to the curtain (22 , 22a) in at least one layer (114, 114a); and at least drying and / or curing the sealant within thirty minutes after applying the sealant as a layer (114, 114a) to the curtain edges (22, 22a).
[18]
18. METHOD according to claim 17, characterized by placing the curtain (22, 22a) on the skin, further including pressing on the second surface of the curtain (22, 22a) in the vicinity of any wrinkles (240) of the curtain (22, 22a).
[19]
19. METHOD according to claim 18, characterized in that it also includes applying a sealant (248) to any edges (244, 246) of the wrinkles (240) after pressing.
[20]
20. METHOD according to any one of claims 17 to 19, characterized in that it also includes applying a sealant as a layer (114, 114a, 248) centered on the curtain edges (22, 22a), joining the sealant to the skin and to the second curtain surface (22, 22a).
[21]
21. METHOD according to any one of claims 17 to 20, characterized in that it also includes the selection of a flexible tube (24, 24a, 24b, 24c) having a first end (40, 60, 1701, 1801, 1901) and a second end connectable to a negative pressure source.
[22]
22. METHOD according to claim 21, characterized in that the first end (40, 60, 1701, 1801, 1901) of the tube (24, 24a, 24b, 24c) (1) is inserted through a flange (26, 26a, 26b, 26c, 26d, 1802) with a central passage (50) through which the first end (40, 60, 1701, 1801, 1901) of the tube (24, 24a, 24b, 24c) is insertable or (2) is coupled to a connector (320) on a flange (26, 26a, 26b, 26c, 26d, 1802) that has a central passage (50) that communicates with the connector (320).
Petition 870190066437, of 7/15/2019, p. 18/20
5/6
[23]
23. METHOD according to claim 22, characterized in that it also includes the application of the sealant that is in a liquid state when applied, the sealant being at least partially cross-linked at least after drying and / or curing, in at least one layer of hair at least one interface between (i) tube (24, 24a, 24b, 24c), (ii) flange (26, 26a, 26b, 26c, 26d, 1802), (iii) tube connector (320), and / or (iv) curtain (22, 22a), so that the seal forms an occlusive seal covering the interface.
[24]
24. METHOD according to any one of claims 17 to 23, characterized in that it also includes the application of the sealant, so that it dries and / or cures in a film or sheet.
[25]
25. METHOD according to any of claims 17 to 24, characterized in that at least the majority of the curtain (22, 22a) and the seal are each derived from a biocompatible latex compound.
[26]
26. METHOD according to any one of claims 17 to 25, characterized in that (i) the biocompatible adhesive is disposed on at least a majority of the second curtain surface (22, 22a) or (ii) at least a second adhesive is arranged on at least a majority of the second curtain surface (22, 22a).
[27]
27. METHOD according to any of claims 17 to 26, characterized in that the sealant adjusts to high levels of tension pressure reached on the surface of the skin during large movements of body deformation, including adjusting the deformation stress of approximately 0 , 45 in tension.
[28]
28. METHOD according to any one of claims 17 to 27, characterized in that it includes the selection of a sealant with low viscosity during its application, having the desired wetting characteristics and allowing it to adjust to all contact surfaces during the process application, including any folds and / or creases in the skin, so that after application no air leakage channel is present at the interface.
[29]
29. METHOD according to any of claims 17 to 28, characterized in that the sealant after drying and / or curing maintains an adhesive bonding strength and adhesive properties by means of Van der Waals forces.
[30]
30. METHOD according to any one of claims 17 to 29, characterized in that it also includes a temporary, controlled air leak in the curative system.
Petition 870190066437, of 7/15/2019, p. 19/20
6/6
[31]
31. METHOD OF BUILDING OCLUSIVE DRESSING on an area of skin with a volume to be sealed, characterized by comprising:
at least one of (1) buffering the volume to be sealed with a fluid-permeable material (104, 304) and / or (2) covering at least part of the volume to be sealed with a protective material (306);
apply an elastomeric material (310) that is in a liquid state, and is at least partially cross-linked at least after drying and / or curing, on at least one of the buffered material (104, 304) and / or the protective material (306) , and on the skin (SK) around the volume to be sealed to create an occlusive curtain, like a thin sheet, significantly impermeable to fluid transfer, having a first inner surface and a second outer surface; and at least drying and / or curing the elastomeric material (310) within thirty minutes after applying the elastomeric material (310) as a layer.
[32]
32. METHOD according to claim 31, characterized by the application including spraying an elastomeric material (310).
[33]
33. METHOD according to claims 31 or 32, characterized in that it further includes applying a biocompatible adhesive to at least a part of the surrounding skin (SK) before applying the elastomeric material (310).
[34]
34. METHOD according to claims 31 to 33, characterized in that it further includes applying the elastomeric material (310) to a tube (24, 24a, 24b, 24c) that has a first end (40, 60, 1701, 1801, 1901 ) and a second end connectable to a negative pressure source.
[35]
35. METHOD according to claim 34, characterized by the first end (40, 60, 1701, 1801, 1901) of the tube (24, 24a, 24b, 24c) (1) passing through a flange (26, 26a, 26b , 26c, 26d, 1802) which has a central passage (50) through which the first end (40, 60, 1701, 1801, 1901) of the tube (24, 24a, 24b, 24c) is insertable or (2) connects with a connector (320) carried by a flange (26, 26a, 26b, 26c, 26d, 1802) which has a central passage (50) communicating with the connector (320).
[36]
36. METHOD according to claims 34 or 35, characterized in that it further includes connecting the second end of the tube to a mechanical vacuum source.

类似技术:

---

公开号 | 公开日 | 专利标题

---

US20210030597A1|2021-02-04|Modifiable Occlusive Skin Dressing

---

US20210228417A1|2021-07-29|Conformable medical dressing with self supporting substrate

---

JP2020523082A|2020-08-06|Composite dressing to promote granulation and reduce maceration during negative pressure treatment

---

US20200146898A1|2020-05-14|Sealing systems and methods employing a hybrid switchable drape

---

RU2701257C2|2019-09-25|Skin care composition delivery device

---

JP2015513424A|2015-05-14|Wound treatment device and covering member therefor

---

BR112019025760A2|2020-06-23|DRESSING TO TREAT A FABRIC PLACE WITH NEGATIVE PRESSURE, APPLIANCE TO TREAT A FABRIC PLACE WITH NEGATIVE PRESSURE, SYSTEM TO TREAT A TISSUE PLACE, USE OF ANY OF THE DRESSINGS, APPLIANCES OR SYSTEMS, METHOD TO TREAT A SURFACE WOUND WITH PRESSURE PRESSURE , METHOD TO PROMOTE GRANULATION IN A SURFACE INJURY AND SYSTEMS, APPLIANCES AND METHODS

---

JP2020523087A|2020-08-06|Customizable composite dressing for promoting granulation and reducing maceration by negative pressure treatment

---

US20130317405A1|2013-11-28|Modular wound dressing

---

US20160095756A1|2016-04-07|Unbacked and Modifiable Tapes and Skin Dressings

---

RU2733721C1|2020-10-06|Plaster for skin care in wet environment

---

WO2020047255A1|2020-03-05|Cooling dressing for improved comfort

---

AU2015360377B2|2020-09-24|Unbacked and modifiable tapes and skin dressings

---

EP2804635B1|2017-12-13|Modifiable occlusive skin dressing

---

JP2022518528A|2022-03-15|Removable and replaceable dressing interface for negative pressure therapy systems

---

Singer0|Danielle ZUROVCIK Negative-Pressure Wound Healing Device

---

CN113795225A|2021-12-14|Manifold with bioactive substances for negative pressure therapy

同族专利:

---

公开号 | 公开日

---

KR102304995B1|2021-09-28|

---

US9173777B2|2015-11-03|

---

KR20200010566A|2020-01-30|

---

JP6162149B2|2017-07-12|

---

KR20140112082A|2014-09-22|

---

AU2013209432B2|2016-11-17|

---

CA2862634A1|2013-07-25|

---

MX2014008664A|2014-11-25|

---

IN2014DN06581A|2015-05-22|

---

US20140031735A1|2014-01-30|

---

RU2669395C2|2018-10-11|

---

US20160045375A1|2016-02-18|

---

US20210030597A1|2021-02-04|

---

JP2015509756A|2015-04-02|

---

CN104066460B|2016-05-18|

---

AU2013209432A1|2014-07-17|

---

WO2013110008A1|2013-07-25|

---

RU2014132838A|2016-03-10|

---

CN104066460A|2014-09-24|

---

KR102067472B1|2020-01-20|

---

MX351280B|2017-10-06|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US4060081A|1975-07-15|1977-11-29|Massachusetts Institute Of Technology|Multilayer membrane useful as synthetic skin|

---

SU854397A1|1979-11-11|1981-08-15|Центральный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Травматологии И Ортопедии Им.Н.Н.Приорова|Device for wound drainage|

---

SU1373741A1|1986-09-30|1988-02-15|Проектно-Технологическое Бюро Всесоюзного Промышленного Объединения По Производству Товаров Бытовой Химии "Союзбытхим"|Cleaning napkin|

---

US5636643A|1991-11-14|1997-06-10|Wake Forest University|Wound treatment employing reduced pressure|

---

US5860420A|1994-03-03|1999-01-19|Rotecno Ag|Surgical draping system having a reusable and a disposable component|

---

AU698477B2|1994-08-22|1998-10-29|Kci Licensing, Inc.|Wound drainage equipment|

---

GB9424562D0|1994-12-06|1995-01-25|Giltech Ltd|Product|

---

GB9523253D0|1995-11-14|1996-01-17|Mediscus Prod Ltd|Portable wound treatment apparatus|

---

EP0921775B1|1996-07-02|2001-12-19|Minnesota Mining And Manufacturing Company|Medical adhesive composite and package|

---

US6068852A|1997-10-11|2000-05-30|Polytherapeutics, Inc.|Polymeric composition for sealing and shielding animal skin|

---

KR100245835B1|1998-02-10|2000-06-01|이양희|Poultice|

---

SE513964C2|1999-03-01|2000-12-04|Moelnlycke Health Care Ab|Wound dressing comprising a layer of a hydrophilic foam|

---

EP1164986B8|1999-04-02|2006-10-25|KCI Licensing, Inc.|Vacuum assisted closure system with heating and cooling provision|

---

GB0105247D0|2001-03-02|2001-04-18|Isis Innovations Ltd|Filter|

---

GB2374014A|2001-04-02|2002-10-09|Cambridge Consultants|Biological sealant storage and dispensing system|

---

RU2225705C2|2001-11-08|2004-03-20|Чухаджян Ара Гарникович|Adhesive film for fixing overdentures|

---

US20040138602A1|2002-10-30|2004-07-15|Rossen Joel S|Simplified one-handed preemptive medical procedure site dressing to prevent sharps injuries and exposure to bloodborne pathogens|

---

SE526906C2|2003-06-10|2005-11-15|Moelnlycke Health Care Ab|Method of applying a protective layer to skin containing a highly viscous silicone composition|

---

SI1629844T1|2004-07-13|2007-12-31|Bayer Schering Pharma Oy|A longterm delivery system with controlled initial burst|

---

US20060030790A1|2004-08-06|2006-02-09|Braig James R|Sample element with barrier material and vacuum|

---

US8061917B2|2005-06-10|2011-11-22|Medlogic Global Limited|Liquid applicator and method of use|

---

US7435423B2|2005-10-05|2008-10-14|Cory Collinge|Wound treatment medium and method of packaging and use|

---

US7988824B2|2005-12-15|2011-08-02|Kimberly-Clark Worldwide, Inc.|Tissue product having a transferable additive composition|

---

EP3040091B1|2006-02-06|2018-06-13|KCI Licensing, Inc.|Systems for improved connection to wound dressings in conjunction with reduced pressure wound treatment systems|

---

KR100899868B1|2007-01-26|2009-05-29|가톨릭대학교 산학협력단|Not-occlusive closed suction drain with irrigation function|

---

BRPI0806192A2|2007-02-09|2014-01-21|Kci Licensing Inc|MANUALLY PUMPED PUMP AND METHOD TO APPLY REDUCED PRESSURE ON A FABRIC SITE|

---

US10117977B2|2007-03-14|2018-11-06|The Board Of Trustees Of The Leland Stanford Junior University|Devices and methods for application of reduced pressure therapy|

---

US20090152137A1|2007-12-14|2009-06-18|Thomas Gregory Estes|Combined Skin Sealant And Incise Drape|

---

WO2009124125A2|2008-04-04|2009-10-08|3M Innovative Properties Company|Medical dressings with valve and kits containing same|

---

EP2305328B1|2008-05-30|2017-11-01|KCI Licensing, Inc.|Reduced pressure, compression systems and apparatuses for use on joints|

---

CA2741737C|2008-10-29|2014-09-09|Kci Licensing, Inc.|Reduced-pressure, deep-tissue closure systems and methods|

---

US8609128B2|2008-10-31|2013-12-17|Adhezion Biomedical, Llc|Cyanoacrylate-based liquid microbial sealant drape|

---

WO2010068502A1|2008-11-25|2010-06-17|Spiracur Inc.|Device for delivery of reduced pressure to body surfaces|

---

US8361043B2|2009-01-07|2013-01-29|Spiracur Inc.|Reduced pressure therapy of the sacral region|

---

EP2223711A1|2009-02-06|2010-09-01|Jap:Ventures Ltd.|Mechanical vacuum source for negative pressure wound therapy and general exudate management|

---

US8728045B2|2009-03-04|2014-05-20|Spiracur Inc.|Devices and methods to apply alternating level of reduced pressure to tissue|

---

US20100274205A1|2009-04-24|2010-10-28|Morelli Rocco R|Wound care kit|

---

EP2467081A4|2009-08-21|2015-05-06|3M Innovative Properties Co|Methods and products for reducing tissue trauma using water-absorbing stress-distributing materials|

---

WO2011022527A1|2009-08-21|2011-02-24|3M Innovative Properties Company|Methods and products for reducing tissue trauma using water-resistant stress-distributing materials|

---

US20110066123A1|2009-09-15|2011-03-17|Aidan Marcus Tout|Medical dressings, systems, and methods employing sealants|

---

DE102010012521A1|2010-03-17|2011-09-22|Aesculap Ag|Medical kit for use in vacuum sealing therapy|

---

US8597264B2|2011-03-24|2013-12-03|Kci Licensing, Inc.|Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds|

---

US20150159066A1|2011-11-25|2015-06-11|Smith & Nephew Plc|Composition, apparatus, kit and method and uses thereof|MX337627B|2010-11-25|2016-03-10|Smith & Nephew|Composition i-ii and products and uses thereof.|

---

EP3354293B1|2012-05-23|2019-12-11|Smith & Nephew plc|Apparatuses for negative pressure wound therapy|

---

AU2013298195B2|2012-08-01|2017-07-13|Smith & Nephew Plc|Wound dressing|

---

US10076449B2|2012-08-01|2018-09-18|Smith & Nephew Plc|Wound dressing and method of treatment|

---

US10085892B2|2013-03-07|2018-10-02|Life Sciences Llc|Apparatus and method for wound infection prevention|

---

US20160030722A1|2013-03-15|2016-02-04|The General Hospital Corporation|Method and apparatus for wound dressing|

---

RU2015143729A|2013-03-15|2017-04-21|СМИТ ЭНД НЕФЬЮ ПиЭлСи|Wound dressing and method of treatment|

---

US10695226B2|2013-03-15|2020-06-30|Smith & Nephew Plc|Wound dressing and method of treatment|

---

EP2926781A1|2014-04-01|2015-10-07|Paul Hartmann AG|Dressing set for negative pressure therapy|

---

WO2016014341A2|2014-07-23|2016-01-28|Boston Scientific Scimed, Inc.|Endoscopic closure device using sealants|

---

AU2015360377B2|2014-12-10|2020-09-24|Worldwide Innovative Healthcare, Inc.|Unbacked and modifiable tapes and skin dressings|

---

US10076594B2|2015-05-18|2018-09-18|Smith & Nephew Plc|Fluidic connector for negative pressure wound therapy|

---

WO2017007660A1|2015-07-03|2017-01-12|Merit Medical Systems, Inc.|Devices and methods for fluid infusion, drainage and collection|

---

EP3117806B1|2015-07-16|2020-06-10|Lohmann & Rauscher GmbH|Wound treatment assembly|

---

DE102015224746A1|2015-12-09|2017-06-14|Paul Hartmann Ag|Connection device for use in the negative pressure therapy of wounds|

---

CA3014884A1|2016-02-18|2017-08-24|Thomas R. GALBIERZ|Medical drape|

---

US11000675B2|2017-04-21|2021-05-11|Donald Griffith|Catheter snugger system and method|

---

RU182497U1|2018-01-17|2018-08-21|Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации|Device for flow-flushing drainage of wounds with adjustable position|

---

EP3773782A4|2018-05-16|2022-03-02|Midwest Training And Dev Services Llc|Negative pressure wound apposition dressing system|

---

WO2020046589A1|2018-08-30|2020-03-05|Kci Licensing, Inc.|Electro-mechanical pump for negative-pressure treatment|

---

WO2021014462A1|2019-07-19|2021-01-28|Payeli Sravan Kumar|Systems for aspiration of fluids|

---

WO2021094972A1|2019-11-13|2021-05-20|Kci Licensing, Inc.|Devices, systems, and methods for delivering a flowable material for use as a tissue dressing|

法律状态:
2018-03-27| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|

---

2019-01-15| B06T| Formal requirements before examination [chapter 6.20 patent gazette]|

---

2019-04-16| B06A| Patent application procedure suspended [chapter 6.1 patent gazette]|

---

2019-10-22| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2019-12-24| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/01/2013, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201261588121P| true| 2012-01-18|2012-01-18|

---

US13/745,690|US9173777B2|2012-01-18|2013-01-18|Modifiable occlusive skin dressing|

---

PCT/US2013/022327|WO2013110008A1|2012-01-18|2013-01-18|Modifiable occlusive skin dressing|

---